FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ribeiro, IS
   Pereira, IS
   Santos, DP
   Lopes, DN
   Prado, AO
   Calado, SPM
   Goncalves, CV
   Galantini, MPL
   Muniz, IPR
   Santos, GS
   Silva, RAA
AF Ribeiro, Israel S.
   Pereira, Italo S.
   Santos, Denisar P.
   Lopes, Danilo N.
   Prado, Alice O.
   Calado, Stefano P. M.
   Goncalves, Caroline, V
   Galantini, Maria P. L.
   Muniz, Igor P. R.
   Santos, Gilvaneia S.
   Silva, Robson A. A.
TI Association between body composition and inflammation: A central role of
   IL-17 and IL-10 in diabetic and hypertensive elderly women
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Systemic arterial hypertension; Type 2 diabetes mellitus; Inflammation;
   Body composition
ID DENSITY LIPOPROTEIN CHOLESTEROL; CARDIO-METABOLIC RISK; MASS INDEX;
   INSULIN-RESISTANCE; WAIST CIRCUMFERENCE; CONCENTRATION RATIO;
   ADIPOSE-TISSUE; BLOOD-PRESSURE; MUSCLE MASS; TGF-BETA
AB In women, aging is evidenced by physiological hormonal alterations that trigger changes in body composition, emergence of chronic low-grade inflammation, which is an important pre-disposition to the development of chronic diseases such as Systemic Arterial Hypertension (SAH) and Type 2 Diabetes Mellitus (T2DM). Although it is a strong pro-inflammatory nature disorder, little is known about how body composition interferes with inflammatory markers in diabetic and hypertensive elderly women. Therefore, this study's objective was to evaluate the inflammation in diabetic and hypertensive elderly women, and their association with fat mass. It comprised the evaluation of 144 women aged between 60 and 80 years old, diagnosed with SAH and T2DM, assisted by Family Health Units in Vitoria da Conquista, Bahia, Brazil. According to body mass index (BMI), these women were classified as either eutrophic or overweight. In the eutrophic females, the IL-10 / IL-17A ratio was increased when compared to those overweight. In addition, IL-17 correlated negatively with HDL and positively with total cholesterol, LDL, triglycerides, VLDL, and glucose in the eutrophic ones, but not in the overweight individuals. IL-10 also showed differences in the correlation pattern observed between the groups, since for this eutrophic cytokine, it presented positive correlation with the waist circumference, waist/height ratio, and negative association with IL-17, while in overweight elderly women, it was not observed such pattern. Hence, this work demonstrates how the amount of fat mass interferes with the balance of cytokines, especially IL-10 and IL-17, and how it may exert an effect on biochemical parameters and risk factors associated with T2DM and SAH.
C1 [Ribeiro, Israel S.; Pereira, Italo S.; Santos, Denisar P.; Lopes, Danilo N.; Prado, Alice O.; Calado, Stefano P. M.; Goncalves, Caroline, V; Galantini, Maria P. L.; Muniz, Igor P. R.; Santos, Gilvaneia S.; Silva, Robson A. A.] Univ Fed Bahia, Multidisciplinary Inst Hlth, Anisio Teixeira Campus,58 Rio de Contas St, BR-45029094 Vitoria Da Conquista, BA, Brazil.
   [Ribeiro, Israel S.] Fed Univ Southern Bahia, Training Ctr Hlth Sci, 58 Joana Angelica Sq, BR-45988058 Teixeira De Freitas, BA, Brazil.
RP Silva, RAA (corresponding author), Univ Fed Bahia, Multidisciplinary Inst Hlth, Anisio Teixeira Campus,58 Rio de Contas St, BR-45029094 Vitoria Da Conquista, BA, Brazil.
EM ramaro@ufba.br
RI Silva, Robson A A/N-8801-2018
OI Goncalves, Caroline/0000-0003-0895-1583; Souza Ribeiro,
   Israel/0000-0002-1262-1387; , Italo/0000-0001-5697-5673
FU Federal University of Bahia (UFBA), Brazil [Prodoc UFBA 04/2014]
FX This work was supported by Federal University of Bahia (UFBA), Brazil,
   under the following grant number: Prodoc UFBA 04/2014.
CR Alvarez-Rodriguez L, 2012, CELL IMMUNOL, V273, P124, DOI 10.1016/j.cellimm.2012.01.001
   American Heart Association (AHA), 2012, WHAT CHOL LEV MEAN T
   Antwi-Baffour S, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0926-y
   Aroor AR, 2013, METABOLISM, V62, P1543, DOI 10.1016/j.metabol.2013.07.001
   Bai B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172271
   Bankoff ADP, 2017, REV SAUDE MEIO AMBIE
   Barbosa Paulo José Bastos, 2006, Arq. Bras. Cardiol., V87, P407, DOI 10.1590/S0066-782X2006001700003
   Baylis Daniel, 2013, Longev Healthspan, V2, P8, DOI 10.1186/2046-2395-2-8
   Bays HE, 2009, AM J MED, V122, pS26, DOI 10.1016/j.amjmed.2008.10.015
   Bellafiore M, 2011, AGING CLIN EXP RES, V23, P378, DOI [10.1007/BF03337762, 10.3275/7354]
   Berecki-Gisolf J, 2009, MENOPAUSE, V16, P1021, DOI 10.1097/gme.0b013e3181a8c49f
   Biadgo B, 2017, ETHIOP J HEALTH SCI, V27, P215, DOI 10.4314/ejhs.v27i3.3
   Bluher S, 2009, AM J CLIN NUTR, V89, p991S, DOI 10.3945/ajcn.2008.26788E
   Britton KA, 2011, CLIN LIPIDOL, V6, P79, DOI 10.2217/CLP.10.89
   Carter RA, 2010, AM J VET RES, V71, P314, DOI 10.2460/ajvr.71.3.314
   CHEN X, 2016, J IMMUNOL RES, V120, P1, DOI DOI 10.1155/2016/1583951
   Chen YL, 2017, IMMUNOL LETT, V186, P52, DOI 10.1016/j.imlet.2017.04.003
   Vilaca KHC, 2014, ARCH GERONTOL GERIAT, V59, P44, DOI 10.1016/j.archger.2014.02.004
   Courville AB, 2014, NUTR RES, V34, P1052, DOI 10.1016/j.nutres.2014.10.007
   De Martinis M, 2006, EXP MOL PATHOL, V80, P219, DOI 10.1016/j.yexmp.2005.11.004
   DeMarco VG, 2014, NAT REV ENDOCRINOL, V10, P364, DOI 10.1038/nrendo.2014.44
   Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264
   Duncan B.B., 2010, MORTALIDADE DOENCAS, P117
   Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437
   Feng RN, 2012, J EPIDEMIOL, V22, P317, DOI 10.2188/jea.JE20110120
   Frikke-Schmidt H, 2016, OBES REV, V17, P795, DOI 10.1111/obr.12429
   Funghetto SS, 2015, CLIN INTERV AGING, V10, P247, DOI 10.2147/CIA.S69711
   Gomes-Rochette NF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169266
   Gundogan K, 2009, METAB SYNDR RELAT D, V7, P427, DOI 10.1089/met.2008.0068
   Harrison DG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00128
   Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074
   Jeevan H.R., 2016, J EVID BASED MED HEA, V53, P2724, DOI [10.18410/jebmh/2016/596, DOI 10.18410/JEBMH/2016/596]
   Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184
   Kasal DA, 2012, HYPERTENSION, V59, P324, DOI 10.1161/HYPERTENSIONAHA.111.181123
   Kinzenbaw DA, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.149
   Kucuk A, 2017, Z RHEUMATOL, V76, P58, DOI 10.1007/s00393-016-0092-4
   Labounty TM, 2013, EUR HEART J-CARD IMG, V14, P456, DOI 10.1093/ehjci/jes179
   Lakoski SG, 2008, ATHEROSCLEROSIS, V197, P443, DOI 10.1016/j.atherosclerosis.2007.06.033
   Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107
   Lima F.E.T., 2016, NE NETWORK NURSING J, V10, P37
   Liu PJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-629
   Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y
   Mahmoud F, 2013, DIS MARKERS, V2013, P235, DOI 10.1155/2013/931915
   Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199
   Malta Deborah Carvalho, 2012, Rev. bras. epidemiol., V15, P639, DOI 10.1590/S1415-790X2012000300017
   Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935
   Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031
   Mayerl C, 2006, VIRCHOWS ARCH, V449, P96, DOI 10.1007/s00428-006-0176-7
   McGill JB, 2011, J NUCL CARDIOL, V18, P421, DOI 10.1007/s12350-011-9362-3
   Miranzi Sybelle de Souza Castro, 2008, Texto contexto - enferm., V17, P672, DOI 10.1590/S0104-07072008000400007
   Motamed M, 2016, CLIN LAB, V62, P1609, DOI 10.7754/Clin.Lab.2016.150412
   Mullugeta Y, 2012, INDIAN J CLIN BIOCHE, V27, P363, DOI 10.1007/s12291-012-0225-8
   Murguia-Romero M, 2013, J LIPID RES, V54, P2795, DOI 10.1194/jlr.M040584
   Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X
   Nascimento DD, 2015, AGING CLIN EXP RES, V27, P791, DOI 10.1007/s40520-015-0349-9
   Olinto Maria Teresa Anselmo, 2006, Cad. Saúde Pública, V22, P1207, DOI 10.1590/S0102-311X2006000600010
   Olinto MTA, 2004, PUBLIC HEALTH NUTR, V7, P629, DOI 10.1079/PHN2003582
   Pereira S, 2014, NUTRITION, V30, P784, DOI 10.1016/j.nut.2013.11.023
   Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333
   Pines A, 2016, CLIMACTERIC, V19, P249, DOI 10.1080/13697137.2016.1175237
   Rabkin SW, 2009, NAT CLIN PRACT CARD, V6, P192, DOI 10.1038/ncpcardio1453
   Rao KM, 2012, ANN HUM BIOL, V39, P54, DOI 10.3109/03014460.2011.637513
   Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237
   Recio-Rodriguez JI, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-3
   Rong YD, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-1007-9
   Sagun G, 2014, CLINICS, V69, P347, DOI 10.6061/clinics/2014(05)09
   Salazar MR, 2013, J INTERN MED, V273, P595, DOI 10.1111/joim.12036
   Salazar MR, 2013, DIABETES VASC DIS RE, V10, P346, DOI 10.1177/1479164113479809
   Salazar MR, 2012, AM J CARDIOL, V109, P1749, DOI 10.1016/j.amjcard.2012.02.016
   de Freitas LRS, 2012, EPIDEMIOL SERV SAUDE, V21, P7, DOI 10.5123/S1679-49742012000100002
   Sapan HB, 2016, INT J BURNS TRAUMA, V6, P37
   Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407
   Schuster DP, 2010, DIABETES METAB SYNDR, V3, P253, DOI 10.2147/DMSO.S7354
   Shirakawa K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186303
   Son JW, 2017, DIABETOLOGIA, V60, P865, DOI 10.1007/s00125-016-4196-9
   Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812
   Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435
   Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805
   Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011
   Sung KC, 2014, DIABETES RES CLIN PR, V105, P96, DOI 10.1016/j.diabres.2014.04.021
   Thacker EL, 2013, J GEN INTERN MED, V28, P247, DOI 10.1007/s11606-012-2220-4
   Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015
   Wakabayashi I, 2004, AGING CLIN EXP RES, V16, P461, DOI 10.1007/BF03327402
   Wei T., 2013, CORRPLOT VISUALIZATI
   Welsh P, 2011, ARTERIOSCL THROM VAS, V31, P2338, DOI 10.1161/ATVBAHA.111.231795
   Zheng S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1020-8
   Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112
   Zhong JX, 2014, DIABETES, V63, P1289, DOI 10.2337/db13-1094
   Zhou L, 2017, OSTEOPOROSIS INT, V28, P1693, DOI 10.1007/s00198-017-3930-6
   Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269
NR 90
TC 1
Z9 1
U1 1
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD NOV
PY 2019
VL 127
AR 110734
DI 10.1016/j.exger.2019.110734
PG 8
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA JH3ZM
UT WOS:000492707500013
PM 31518664
DA 2020-12-08
ER

PT J
AU dos Santos, DP
   Lopes, DPS
   de Moraes, RC
   Goncalves, CV
   Rosa, LP
   Rosa, FCD
   da Silva, RAA
AF dos Santos, Denisar Palmito
   Soares Lopes, Diego Patrick
   de Moraes Junior, Ricardo Costa
   Goncalves, Caroline Vieira
   Rosa, Luciano Pereira
   da Silva Rosa, Francine Cristina
   Augusto da Silva, Robson Amaro
TI Photoactivated resveratrol against Staphylococcus aureus infection in
   mice
SO PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
LA English
DT Article
DE Staphylococcus aureus; Photodynamic therapy; Resveratrol
ID TUMOR-NECROSIS-FACTOR; ANTIMICROBIAL PHOTODYNAMIC THERAPY; BLUE-LIGHT;
   SINGLET OXYGEN; FACTOR-ALPHA; CELLS; PHOTOSENSITIZERS; INFLAMMATION;
   MACROPHAGES; EXPRESSION
AB Background : Among the pathogens, Staphylococcus aureus is the main causative agent of bacterial diseases in the world. In this context, antimicrobial photodynamic therapy (aPDT) appears as a promising tool by means of microbial inactivation with the use of light. aPDT is applied in treatments involving photosensitizers capable of generating oxygen free radicals. Thus, this work proposes the use of resveratrol as a photosensitizer.
   Methods: In vitro tests were performed to determine the antibacterial activity of photoactivated resveratrol with blue LED light, as well as uric acid experiments for verification of singlet oxygen formation. Possible resveratrol structural changes were evaluated by HPLC. In the in vivo assays, the air pouch model was performed in mice for antimicrobial activity and cytokine production.
   Results: The photoactivated resveratrol exhibited an increase in its antibacterial action and it is possibly brought about by the singlet oxygen formation. In the air pouch model, TNF-alpha and IL-17A cytokines were produced, diminishing the bacterial load, and consequently, reducing inflammation after 24 h of infection. Cellular number decrease in the inflammatory environment was associated with resolution of inflammation along with greater IL-10 production.
   Conclusion: It is the first time that resveratrol has been associated with aPDT. It was demonstrated in this work that resveratrol activated by blue LED light can be a promising photosensitizer. This compound, after the light stimulus, produces singlet oxygen, in addition to having effects on the immune system triggering TNF-alpha and IL-17A production, aiding in the clearance of several bacteria, including S. aureus.
C1 [dos Santos, Denisar Palmito; Soares Lopes, Diego Patrick; de Moraes Junior, Ricardo Costa; Goncalves, Caroline Vieira; Rosa, Luciano Pereira; da Silva Rosa, Francine Cristina; Augusto da Silva, Robson Amaro] Univ Fed Bahia, Multidisciplinary Inst Hlth, Anisio Teixeira Campus,58 Rio de Contas St, BR-45029094 Vitoria Da Conquista, BA, Brazil.
RP da Silva, RAA (corresponding author), Univ Fed Bahia, Multidisciplinary Inst Hlth, Anisio Teixeira Campus,58 Rio de Contas St, BR-45029094 Vitoria Da Conquista, BA, Brazil.
EM robson.amaro@gmail.com
RI Silva, Robson A A/N-8801-2018
OI Goncalves, Caroline/0000-0003-0895-1583
FU Institutional Program of Scientific Initiation of Federal University of
   Bahia; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior) foundation for the phD grant
FX This study was funded by the Institutional Program of Scientific
   Initiation of Federal University of Bahia for the Scientific Initiation
   scholarships awarded, and by the Research Center in Optics and Photonics
   (CePOF) for the equipment to the development of this work. Authors want
   to acknowledge financial support from CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior) foundation for the phD
   grant.
CR Abrahamse H, 2016, BIOCHEM J, V473, P347, DOI 10.1042/BJ20150942
   Al-Mutairi R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01699
   Al-Omari S, 2009, GEN PHYSIOL BIOPHYS, V28, P70, DOI 10.4149/gpb_2009_01_70
   Almeida PP, 2017, LASER MED SCI, V32, P1337, DOI 10.1007/s10103-017-2247-1
   Alvarez C, 2010, BRAZ J INFECT DIS, V14, pS107, DOI 10.1590/S1413-86702010000800006
   Archer NK, 2013, INFECT IMMUN, V81, P2070, DOI 10.1128/IAI.00084-13
   BELLNIER DA, 1991, J PHOTOCH PHOTOBIO B, V8, P203, DOI 10.1016/1011-1344(91)80060-U
   Benitez DA, 2009, PROSTATE, V69, P1045, DOI 10.1002/pros.20953
   Bostanghadiri N, 2017, BIOMED PHARMACOTHER, V95, P1588, DOI 10.1016/j.biopha.2017.09.084
   Cassidy CM, 2010, J PHOTOCH PHOTOBIO B, V99, P62, DOI 10.1016/j.jphotobiol.2010.02.004
   Chalal M, 2014, MOLECULES, V19, P7679, DOI 10.3390/molecules19067679
   Chan MMY, 2002, BIOCHEM PHARMACOL, V63, P99, DOI 10.1016/S0006-2952(01)00886-3
   Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x
   Coutinho DD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061812
   Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800
   Cypowyj S, 2012, EUR J IMMUNOL, V42, P2246, DOI 10.1002/eji.201242605
   DAHL TA, 1987, PHOTOCHEM PHOTOBIOL, V46, P345, DOI 10.1111/j.1751-1097.1987.tb04779.x
   DAS UN, 1990, BIOCHEM BIOPH RES CO, V167, P1030, DOI 10.1016/0006-291X(90)90626-X
   Ding HY, 2011, J CONTROL RELEASE, V156, P276, DOI 10.1016/j.jconrel.2011.08.019
   dos Santos DP, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431x20186773, 10.1590/1414-431X20186773]
   Duarte Djane B, 2016, Curr Protoc Pharmacol, V72, DOI 10.1002/0471141755.ph0506s72
   EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205
   Eo SH, 2013, BIOMOL THER, V21, P364, DOI 10.4062/biomolther.2013.029
   EVANS S, 1990, J NATL CANCER I, V82, P34, DOI 10.1093/jnci/82.1.34
   Fischer F, 1998, CLIN CHIM ACTA, V274, P89, DOI 10.1016/S0009-8981(98)00045-X
   Pansa MF, 2016, TUMOR BIOL, V37, P541, DOI 10.1007/s13277-015-3768-5
   Fu XJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/159157
   Garcia VG, 2014, J PERIODONTAL RES, V49, P584, DOI 10.1111/jre.12138
   Gelatti LC, 2009, AN BRAS DERMATOL, V84, P501, DOI 10.1590/S0365-05962009000500009
   Giersing BK, 2016, VACCINE, V34, P2962, DOI 10.1016/j.vaccine.2016.03.110
   Gois MM, 2010, LASER MED SCI, V25, P391, DOI 10.1007/s10103-009-0705-0
   Gomes AR, 2006, ANTIMICROB AGENTS CH, V50, P3237, DOI 10.1128/AAC.00521-06
   Grinholc M, 2007, ACTA BIOCHIM POL, V54, P665, DOI 10.18388/abp.2007_3240
   Guo YY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/6/065102
   Hanakova A, 2014, MICROBIOL RES, V169, P163, DOI 10.1016/j.micres.2013.07.005
   Hayashi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122351
   Hempstead J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10093
   Huang LY, 2012, LASER SURG MED, V44, P490, DOI 10.1002/lsm.22045
   Huang YY, 2012, EXPERT REV CLIN IMMU, V8, P479, DOI [10.1586/ECI.12.37, 10.1586/eci.12.37]
   Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30
   Jeong SI, 2016, NEUROBIOL AGING, V44, P74, DOI 10.1016/j.neurobiolaging.2016.04.007
   Jiang HN, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00191
   Kane T., 2016, CURR DRUG TARGETS
   Kapetanovic R, 2011, AM J PHYSIOL-CELL PH, V300, pC850, DOI 10.1152/ajpcell.00187.2010
   Kashef N, 2017, DRUG RESIST UPDATE, V31, P31, DOI 10.1016/j.drup.2017.07.003
   Kashiwabuchi RT, 2012, ARQ BRAS OFTALMOL, V75, P423, DOI 10.1590/S0004-27492012000600011
   Lancon A, 2016, MOLECULES, V21, DOI 10.3390/molecules21030304
   Larysz-Brysz M, 2012, CURR NEUROVASC RES, V9, P159, DOI 10.2174/156720212801619045
   Lauridsen HM, 2017, AM J PATHOL, V187, P1893, DOI 10.1016/j.ajpath.2017.04.008
   Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229
   Li R, 2016, INT J BIOCHEM CELL B, V71, P55, DOI 10.1016/j.biocel.2015.12.001
   Lida S, 2017, J CLIN BIOCHEM NUTR, V61, P169, DOI 10.3164/jcbn.17-24
   Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703
   Liu GY, 2009, PEDIATR RES, V65, p71R, DOI 10.1203/PDR.0b013e31819dc44d
   Liu YH, 2011, J IMMUNOL, V186, P3197, DOI 10.4049/jimmunol.1002016
   Lorenzon E. N., 2018, SCI REP, V8, P1, DOI DOI 10.1038/S41598-018-22687-X
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Maisch T, 2007, P NATL ACAD SCI USA, V104, P7223, DOI 10.1073/pnas.0611328104
   Mamalis A, 2016, DERMATOL SURG, V42, P727, DOI 10.1097/DSS.0000000000000744
   Manoil D, 2014, PHOTODIAGN PHOTODYN, V11, P372, DOI 10.1016/j.pdpdt.2014.06.003
   de Melo WDMA, 2013, PHOTODIAGN PHOTODYN, V10, P647, DOI 10.1016/j.pdpdt.2013.08.001
   Morimoto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105173
   Musser DA, 2001, PHOTOCHEM PHOTOBIOL, V73, P518, DOI 10.1562/0031-8655(2001)073<0518:COTIIB>2.0.CO;2
   Niu TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138754
   Panhoca VH, 2016, PHOTOMED LASER SURG, V34, P411, DOI 10.1089/pho.2015.4080
   Park HJ, 2013, MICROBIOL IMMUNOL, V57, P547, DOI 10.1111/1348-0421.12070
   Ribeiro JBP, 2016, PHOTODIAGN PHOTODYN, V13, P282, DOI 10.1016/j.pdpdt.2015.08.006
   Ragas X, 2013, MOLECULES, V18, P2712, DOI 10.3390/molecules18032712
   Rodriguez-Cabo T, 2015, J CHROMATOGR A, V1410, P129, DOI 10.1016/j.chroma.2015.07.088
   Rosa LP, 2015, PHOTODIAGN PHOTODYN, V12, P276, DOI 10.1016/j.pdpdt.2015.01.001
   SELMAN SH, 1987, J UROLOGY, V137, P1255, DOI 10.1016/S0022-5347(17)44476-4
   STEUBING RW, 1991, J PHOTOCH PHOTOBIO B, V10, P133, DOI 10.1016/1011-1344(91)80218-7
   Szliszka E, 2011, CENT EUR J UROL, V64, P175, DOI 10.5173/ceju.2011.03.art18
   Teixeira CR, 2005, J IMMUNOL, V175, P8346, DOI 10.4049/jimmunol.175.12.8346
   Tortik N, 2014, PHOTOCH PHOTOBIO SCI, V13, P1402, DOI 10.1039/c4pp00123k
   Uesugi D, 2016, NAT PROD COMMUN, V11, P199
   Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026
   Leite DPV, 2014, PHOTOMED LASER SURG, V32, P627, DOI 10.1089/pho.2014.3805
   Wenzel RP, 1998, CLIN INFECT DIS, V27, P245, DOI 10.1086/514646
   Werner JL, 2011, INFECT IMMUN, V79, P3966, DOI 10.1128/IAI.05493-11
   Wu J. Y., 2012, YI XUE BAN, V43, P382
   Yang I, 2012, CHEM COMMUN, V48, P3839, DOI 10.1039/c2cc30940h
   Zheng X, 2013, EUR J PHARM
   Zhou ZX, 2018, MOL MED REP, V17, P1269, DOI 10.3892/mmr.2017.7933
   Zioikowski P, 1997, NEOPLASMA, V44, P192
NR 85
TC 1
Z9 1
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1572-1000
EI 1873-1597
J9 PHOTODIAGN PHOTODYN
JI Photodiagnosis Photodyn. Ther.
PD MAR
PY 2019
VL 25
BP 227
EP 236
DI 10.1016/j.pdpdt.2019.01.005
PG 10
WC Oncology
SC Oncology
GA HU1VJ
UT WOS:000465059600033
PM 30630110
DA 2020-12-08
ER

PT J
AU dos Santos, DP
   Lopes, DPS
   Calado, SPD
   Goncalves, CV
   Muniz, IPR
   Ribeiro, IS
   Galantini, MPL
   da Silva, RAA
AF dos Santos, Denisar Palmito
   Soares Lopes, Diego Patrick
   de Melo Calado, Stefano Pedro
   Goncalves, Caroline Vieira
   Ribeiro Muniz, Igor Pereira
   Ribeiro, Israel Souza
   Leite Galantini, Maria Poliana
   Augusto da Silva, Robson Amaro
TI Efficacy of photoactivated Myrciaria cauliflora extract against
   Staphylococcus aureus infection - A pilot study
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Staphylococcus aureus; Photodynamic therapy; Photosensitizers; Myrciaria
   cauliflora
ID PHOTODYNAMIC THERAPY; CHEMICAL-CHARACTERIZATION; INTRADERMAL INFECTION;
   NATURAL DYE; S. AUREUS; IN-VITRO; SKIN; ANTIOXIDANT; CURCUMIN; CANCER
AB Staphylococcus aureus is one of the major microorganisms that cause human diseases, leading from mild skin infections to serious diseases. With the use of semi-synthetic penicillins, methicillin-resistant strains called Methicillin-resistant Staphylococcus aureus (MRSA) have emerged, whose resistance pattern extends to other beta-lactam antibiotics. It has already been shown that photodynamic therapy is capable of inactivating MRSA as the laser excites the photosensitizer responsible for transferring its electrons to the molecular oxygen, generating extremely reactive molecules, such as singlet oxygen, being these reactive components the chemicals that promote the bacterial clearance. Thus, the research aiming at the development of new photosensitizers becomes important, especially to increase the amount of therapeutic resources available for the treatment of persistent infections related to this bacterium. In this context, Myrciaria cauliflora is a plant that has antimicrobial action and there are no reports of the use of its crude extract as a photosensitizer in antimicrobial photodynamic therapy. In that way, this work conveys an innovative way of the use of M. cauliflora extract as a photosensitizer, comprising its use as an antimicrobial agent when activated by light, against S. aureus. In vitro tests were performed where it was observed that after the photoactivation with blue LED light, the extract presented an augment in its antimicrobial activity, together with production of singlet oxygen. In the model of intradermal infection in Balb/c mice, a reduction in bacterial load was also detected, with raised expression of TNF-alpha, IL-17A, and MPO. Here, we demonstrate that the extract of M. cauliflora has photosensitizing action, promoting the production of singlet oxygen, besides IL-17A, TNF-alpha, and MPO.
C1 [dos Santos, Denisar Palmito; Soares Lopes, Diego Patrick; de Melo Calado, Stefano Pedro; Goncalves, Caroline Vieira; Ribeiro Muniz, Igor Pereira; Ribeiro, Israel Souza; Leite Galantini, Maria Poliana; Augusto da Silva, Robson Amaro] Univ Fed Bahia, Multidisciplinary Inst Hlth, Anisio Teixeira Campus,58 Rio de Contas St, BR-45029094 Vitoria Da Conquista, BA, Brazil.
RP da Silva, RAA (corresponding author), Univ Fed Bahia, Multidisciplinary Inst Hlth, Anisio Teixeira Campus,58 Rio de Contas St, BR-45029094 Vitoria Da Conquista, BA, Brazil.
EM robson.amaro@gmail.com
RI Silva, Robson A A/N-8801-2018
OI Souza Ribeiro, Israel/0000-0002-1262-1387; Goncalves,
   Caroline/0000-0003-0895-1583; Lopes, Diego/0000-0002-9211-5758
FU Coordination for Improvement of Higher Education Personnel (CAPES)CAPES;
   Research Center in Optics and Photonics (CePOF)
FX This study was funded by Coordination for Improvement of Higher
   Education Personnel (CAPES) for the Institutional Program of Scientific
   Initiation of Federal University of Bahia, and by the Research Center in
   Optics and Photonics (CePOF) for the equipment to the development of
   this work.
CR Aleixandre-Gorriz I, 2014, REV ESP QUIM, V27, P215
   Almeida PP, 2017, LASER MED SCI, V32, P1337, DOI 10.1007/s10103-017-2247-1
   Souza MPA, 2017, IRAN J ALLERGY ASTHM, V16, P525
   Alves F, 2017, LASER MED SCI, V32, P815, DOI 10.1007/s10103-017-2177-y
   AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858
   Baldin JC, 2016, MEAT SCI, V118, P15, DOI 10.1016/j.meatsci.2016.03.016
   Bartlett AH, 2010, PEDIATR INFECT DIS J, V29, P860, DOI 10.1097/INF.0b013e3181ef2477
   Bassetti M, 2017, CURR OPIN INFECT DIS, V30, P150, DOI [10.1097/QCO.0000000000000353, 10.1097/qco.0000000000000353]
   Lima ADB, 2008, ARCH LATINOAM NUTR, V58, P416
   Branco TM, 2018, PHOTODIAGN PHOTODYN, V21, P285, DOI 10.1016/j.pdpdt.2018.01.001
   Bregnhoj M, 2019, PHOTOCHEM PHOTOBIOL, V95, P202, DOI 10.1111/php.12971
   Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891
   Claeys KC, 2018, INT J ANTIMICROB AG, V51, P43, DOI 10.1016/j.ijantimicag.2017.05.015
   Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5
   Cortes DF, 2010, MEM I OSWALDO CRUZ, V105, P736, DOI 10.1590/S0074-02762010000600002
   de Araujo FP, 2018, INFECTION, V46, P49, DOI 10.1007/s15010-017-1084-2
   de Jong NWM, 2018, J BIOL CHEM, V293, P2260, DOI 10.1074/jbc.RA117.000134
   Ribeiro APD, 2013, LASER MED SCI, V28, P391, DOI 10.1007/s10103-012-1064-9
   Dmitriev BA, 2004, J BACTERIOL, V186, P7141, DOI 10.1128/JB.186.21.7141-7148.2004
   dos Santos DP, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431x20186773, 10.1590/1414-431X20186773]
   Dunlap W. C., 1998, International Journal of Cosmetic Science, V20, P1, DOI 10.1046/j.1467-2494.1998.171731.x
   Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491
   Haddar W, 2018, NAT PROD RES, V32, P141, DOI 10.1080/14786419.2017.1342080
   Hampton MB, 1996, INFECT IMMUN, V64, P3512, DOI 10.1128/IAI.64.9.3512-3517.1996
   Hardgrib N, 2016, ACTA RADIOL OPEN, V5, DOI 10.1177/2058460116677180
   Huang LY, 2012, LASER SURG MED, V44, P490, DOI 10.1002/lsm.22045
   Kacerovska D, 2008, PHOTOCHEM PHOTOBIOL, V84, P779, DOI 10.1111/j.1751-1097.2007.00260.x
   Kapsokalyvas D, 2005, J PHOTOCH PHOTOBIO B, V80, P208, DOI 10.1016/j.jphotobiol.2005.04.007
   Kobayashi SD, 2015, AM J PATHOL, V185, P1518, DOI 10.1016/j.ajpath.2014.11.030
   Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
   Lee HJ, 2017, PHOTODIAGN PHOTODYN, V20, P116, DOI 10.1016/j.pdpdt.2017.09.003
   Leech JM, 2017, J IMMUNOL, V198, P2352, DOI 10.4049/jimmunol.1601018
   Liu C, 2018, J INFECT DIS, V218, P64, DOI 10.1093/infdis/jiy149
   Lushniak BD, 2014, PUBLIC HEALTH REP, V129, P314, DOI 10.1177/003335491412900402
   Mai BJ, 2017, INT J NANOMED, V12, P5915, DOI 10.2147/IJN.S138185
   Castano-Jaramillo LM, 2017, REV CHIL INFECTOL, V34, P487, DOI 10.4067/S0716-10182017000500487
   Hacke ACM, 2016, J FOOD SCI, V81, pC2206, DOI 10.1111/1750-3841.13405
   Monteiro JSC, 2017, LASER MED SCI, V32, P29, DOI 10.1007/s10103-016-2079-4
   Nakagawa S, 2017, CELL HOST MICROBE, V22, P667, DOI 10.1016/j.chom.2017.10.008
   Pan L, 2017, MAT SCI ENG C-MATER, V75, P1448, DOI 10.1016/j.msec.2017.03.021
   Parcina M, 2013, J IMMUNOL, V190, P1591, DOI 10.4049/jimmunol.1201222
   Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387
   Prabhakara R, 2013, INFECT IMMUN, V81, P1306, DOI 10.1128/IAI.01304-12
   Reynertson KA, 2006, J NAT PROD, V69, P1228, DOI 10.1021/np0600999
   Ryu S, 2014, INT J MOL SCI, V15, P8753, DOI 10.3390/ijms15058753
   Saitawee D, 2018, PHOTODIAGN PHOTODYN, V22, P101, DOI 10.1016/j.pdpdt.2018.03.001
   Van Puyvelde S., 2017, LANCET INFECT DIS
   van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1
   Wang CK, 2017, MOLECULES, V22, DOI 10.3390/molecules22112037
   Wang JH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00606
   Wozniak A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00930
   Ye Y, 2014, INT J NANOMED, V9, P5157, DOI 10.2147/IJN.S71365
   Yoo JO, 2012, INT REV CEL MOL BIO, V295, P139, DOI 10.1016/B978-0-12-394306-4.00010-1
   Zhan XY, 2018, INFECT GENET EVOL, V59, P16, DOI 10.1016/j.meegid.2018.01.018
   Zhao K. Q., 2018, JOVE-J VIS EXP, V12
NR 55
TC 4
Z9 4
U1 1
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD FEB
PY 2019
VL 191
BP 107
EP 115
DI 10.1016/j.jphotobiol.2018.12.011
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA HL4RW
UT WOS:000458711800015
PM 30599381
DA 2020-12-08
ER

PT J
AU Sharma, R
   Santos, LC
   da Silva, RA
   Goncalves, CV
   Calado, SD
   Santos, DP
   de Melo, JPD
   Rampazzo, RDP
   Requiao, L
   Krieger, MA
   Barral-Netto, M
   de Oliveira, CI
AF Sharma, Rohit
   Santos, Larissa Costa
   da Silva, Robson A.
   Goncalves, Caroline V.
   Calado, Stefano de Melo
   Santos, Denisar P.
   de Andrade de Melo, Josana P.
   Pontello Rampazzo, Rita de Cassia
   Requiao, Luciana
   Krieger, Marco A.
   Barral-Netto, Manoel
   de Oliveira, Camila I.
TI Surveillance of donated blood during the 2016 arbovirus outbreak in
   Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE NAT; transfusion; ZIKV
ID ZIKA VIRUS; PUERTO-RICO; TRANSFUSION; TRANSMISSION; DONORS; STATES; RNA
AB Reports of arboviral transmission via blood transfusion may be a cause of concern among asymptomatic infected donors. This study evaluated the presence of arboviruses in donated blood products during the 2016 outbreak in Vitoria da Conquista (Bahia-Brazil). Serum samples (n=676) were screened for ZIKV, CHIKV, and the four DENV serotypes using a one-step reverse transcriptase-based Real-Time Polymerase Chain Reaction (RT-PCR). No samples tested positive for any of the targets, whereas positive controls performed as expected. The results suggest a low risk of arboviral transmission via transfusion of blood products in the endemic area studied during the 2016 outbreak.
C1 [Sharma, Rohit; Santos, Larissa Costa; Barral-Netto, Manoel; de Oliveira, Camila I.] Fiocruz MS, IGM, Salvador, BA, Brazil.
   [da Silva, Robson A.; Goncalves, Caroline V.; Calado, Stefano de Melo; Santos, Denisar P.] UFBA, IMS, Vitoria Da Conquista, BA, Brazil.
   [de Andrade de Melo, Josana P.] Serv Hemoterapia Sudoeste, Vitoria Da Conquista, PR, Brazil.
   [Pontello Rampazzo, Rita de Cassia; Requiao, Luciana; Krieger, Marco A.] IBMP, Curitiba, PR, Brazil.
   [Krieger, Marco A.] Fiocruz MS, ICC, Curitiba, PR, Brazil.
   [Barral-Netto, Manoel; de Oliveira, Camila I.] Inst Nacl Ciencia & Tecnol Invest Imunol, Sao Paulo, SP, Brazil.
RP de Oliveira, CI (corresponding author), Fiocruz MS, IGM, Rua Waldemar Falcao 121, BR-40196710 Candeal Salvador, BA, Brazil.
EM camila@bahia.fiocruz.br
RI de Oliveira, Camila I/B-4358-2009; Rampazzo, Rita/AAA-4590-2020; Silva,
   Robson A A/N-8801-2018; Krieger, Marco/AAE-8611-2020; Barral Netto,
   Manoel/B-3904-2009
OI de Oliveira, Camila I/0000-0002-7868-5164; Rampazzo,
   Rita/0000-0002-8367-999X; Barral Netto, Manoel/0000-0002-5823-7903;
   Goncalves, Caroline/0000-0003-0895-1583
FU CAPES FellowshipCAPES
FX CAPES Fellowship
CR Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Santa Maria F, 2017, TRANSFUSION, V57, P2016, DOI 10.1111/trf.14161
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
NR 19
TC 1
Z9 1
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD AUG
PY 2018
VL 90
IS 8
BP 1406
EP 1410
DI 10.1002/jmv.25193
PG 5
WC Virology
SC Virology
GA GK0JY
UT WOS:000435797200020
PM 29667206
DA 2020-12-08
ER

PT J
AU dos Santos, DP
   Muniz, IPR
   Queiroz, AF
   Pereira, IS
   Souza, MPA
   Lima, LJ
   Sousa, LRO
   Ribeiro, IS
   Galantini, MPL
   Marques, LM
   Figueiredo, TB
   da Silva, RAA
AF dos Santos, D. P.
   Muniz, I. P. R.
   Queiroz, A. F.
   Pereira, I. S.
   Souza, M. P. A.
   Lima, L. J.
   Sousa, L. R. O.
   Ribeiro, I. S.
   Galantini, M. P. L.
   Marques, L. M.
   Figueiredo, T. B.
   da Silva, R. A. A.
TI Individual variation is the key to the development of a vaccine against
   Staphylococcus aureus: a comparative study between mice lineages
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Immunization; Staphylococcus aureus; Mice; Air pouch; Antibodies
ID COMPLEMENT COMPONENT C5; ANTIBODY-RESPONSE; IMMUNE-RESPONSES;
   TEICHOIC-ACID; HOST-DEFENSE; INFECTION; SYSTEM; A/J; INTERLEUKIN-17A;
   SUSCEPTIBILITY
AB Bacterial infections occur worldwide and are a major public health problem. Among pathogens, Staphylococcus aureus is the main causative agent of bacterial diseases in the world. This study aimed to evaluate which components of the immune system could act protectively against a S. aureus infection in intradermally immunized mice. C57BL/6 and A/j mice were immunized intradermally with S. aureus inactivated by heat and then challenged with viable strains in an air pouch model. At 6, 12, and 24 h after the challenge, euthanasia was performed, and the cellular profile of the inflammatory infiltrate, cytokines, and the bacterial load were evaluated in the air pouch lavages. Immunized mice demonstrated that the intradermal immunization with S. aureus promoted protection in C57BL/6 mice by reducing the bacterial, which was correlated with increased serum concentration of IgG antibodies (IgG1 and IgG2a) against S. aureus. The increase in IgG2a antibody levels was correlated with a decrease of bacterial load in intradermally immunized C57BL/6 mice, along with production of IL-17A at the inflammation site, as well as IgG1 consumption. Similar results were not found in the A/j lineage. In conclusion, a vaccine against S. aureus should focus more on the individual characteristics of the host because it is a determinant factor for the success of the immunization.
C1 [dos Santos, D. P.; Muniz, I. P. R.; Queiroz, A. F.; Pereira, I. S.; Souza, M. P. A.; Lima, L. J.; Sousa, L. R. O.; Ribeiro, I. S.; Galantini, M. P. L.; Marques, L. M.; Figueiredo, T. B.; da Silva, R. A. A.] Univ Fed Bahia, Inst Multidisciplinar Saude, Vitoria Da Conquista, BA, Brazil.
RP dos Santos, DP (corresponding author), Univ Fed Bahia, Inst Multidisciplinar Saude, Vitoria Da Conquista, BA, Brazil.
EM farmapalmito@gmail.com
RI Silva, Robson A A/N-8801-2018
OI Souza Ribeiro, Israel/0000-0002-1262-1387; , Italo/0000-0001-5697-5673
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Instituto Multidisciplinar em Saude, Universidade Federal
   da Bahia, Campus Anisio Teixeira
FX This study was supported by grants from Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES). We also thank the financial
   contribution from the Instituto Multidisciplinar em Saude, Universidade
   Federal da Bahia, Campus Anisio Teixeira.
CR Alvarez C, 2010, REV CHIL INFECTOL, V27, pS81
   Archer NK, 2013, INFECT IMMUN, V81, P2070, DOI 10.1128/IAI.00084-13
   Bavia L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/491641
   Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114
   Cypowyj S, 2012, EUR J IMMUNOL, V42, P2246, DOI 10.1002/eji.201242605
   FARRELL C, 1975, SCAND J IMMUNOL, V4, P673, DOI 10.1111/j.1365-3083.1975.tb02675.x
   Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537
   HAMMARSTROM L, 1984, CLIN EXP IMMUNOL, V55, P593
   Hua Guoqiang, 2013, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-7091-1511-4_2
   Inoue S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-283
   Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123
   Jagannath C, 2000, SCAND J IMMUNOL, V52, P369, DOI 10.1046/j.1365-3083.2000.00770.x
   Joshi Amita, 2012, Hum Vaccin Immunother, V8, P336, DOI 10.4161/hv.18946
   Jovicic N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134089
   Jung DJ, 2012, J IMMUNOL, V189, P4951, DOI 10.4049/jimmunol.1201294
   Kobayashi SD, 2015, AM J PATHOL, V185, P1518, DOI 10.1016/j.ajpath.2014.11.030
   Missiakas D, 2016, J EXP MED, V213, P1645, DOI 10.1084/jem.20160569
   Montgomery CP, 2014, INFECT IMMUN, V82, P2125, DOI 10.1128/IAI.01491-14
   MORRISON WI, 1985, PARASITE IMMUNOL, V7, P63, DOI 10.1111/j.1365-3024.1985.tb00479.x
   Mullick A, 2006, INFECT IMMUN, V74, P4439, DOI 10.1128/IAI.00159-06
   Murphy AG, 2014, J IMMUNOL, V192, P3697, DOI 10.4049/jimmunol.1303420
   Pellegrino M, 2016, VACCINE, V34, P3356, DOI 10.1016/j.vaccine.2016.05.014
   Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3
   Rivas AL, 2007, CAN J VET RES, V71, P135
   Saputra S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176379
   Sasaki S, 2006, FEMS IMMUNOL MED MIC, V46, P367, DOI 10.1111/j.1574-695X.2005.00037.x
   Selle M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24754
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Garcia-Romo GS, 2015, MICROBIOL IMMUNOL, V59, P193, DOI 10.1111/1348-0421.12241
   Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x
   Tkaczyk C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075103
   Torre A, 2015, INFECT IMMUN, V83, P3157, DOI 10.1128/IAI.00258-15
   Turner RB, 2016, ANTIMICROB AGENTS CH, V60, P5682, DOI 10.1128/AAC.00439-16
   van de Veerdonk FL, 2009, BMB REP, V42, P776, DOI 10.5483/BMBRep.2009.42.12.776
   Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561
   WETSEL RA, 1990, J BIOL CHEM, V265, P2435
   ZHENG LM, 1993, EUR J IMMUNOL, V23, P2826, DOI 10.1002/eji.1830231116
NR 37
TC 3
Z9 3
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 2018
VL 51
IS 5
AR e6773
DI 10.1590/1414-431X20186773
PG 12
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA GA8EB
UT WOS:000428569900001
PM 29590259
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Souza, MPA
   Lima, FMD
   Muniz, IP
   Pereira, IS
   Sousa, LRD
   Galantini, MPL
   dos Santos, DP
   Figueiredo, TB
   da Silva, RAA
AF Almeida Souza, Marcos Paulo
   da Silva Lima, Fernanda Macedo
   Muniz, Igor Pereira
   Pereira, Italo Sousa
   de Oliveira Sousa, Larissa Rodrigues
   Leite Galantini, Maria Poliana
   dos Santos, Denisar Palmito
   Figueiredo, Tiana Baqueiro
   Augusto da Silva, Robson Amaro
TI Ovariectomy Modifies TH2, and TH17 Balance in BALB/C Allergic Mice
SO IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY
LA English
DT Article
DE Airway inflammation; Asthma; IL-17A; Ovariectomy; Sex hormones
ID ESTROGEN-RECEPTOR-ALPHA; MURINE ASTHMA MODEL; REGULATORY T-CELLS; AIRWAY
   INFLAMMATION; LUNG INFLAMMATION; SEX-DIFFERENCES; GLOBAL BURDEN; MOUSE
   MODEL; RESPONSES; SYMPTOMS
AB Asthma is a chronic inflammation of the airways affecting over 300 million people worldwide. As in the autoimmune diseases, it is well described that women are the most affected by asthma. The higher number of women presenting this pathology suggests the involvement of female sex hormones in the construction of the allergic immune response.
   Female Balb/c mice were used for the experiments. Thirty-eight animals were separated into four groups: OVX-Ova; Sham-Ova; OVX-Sal; Sham-Sal. Then animals underwent acute allergic induction protocol by Ovalbulmin (OVA). Ovariectomized animals showed greater number of leukocytes in bronchoalveolar lavage (BAL) and elevated white blood cells recruitment to the lung environment observed by histological analysis.
   There was a significant increase of eosinophils and mast cells in inflammatory sites at pulmonary tissue. The relative uterine and body weight were lower in ovariectomized animals and higher in Sham mice, respectively. Moreover, the lack of the sex hormones induced an increase in interleukin (IL)-4 and titers of immunoglobulin G1 (IgG1) antibodies. However, increased production of IL-17A was only observed in Sham animals.
   Altogether, data this study suggest that ovariectomy induces the formation of a stronger Th-2 response in allergic animal. However, the immune processes involved in the allergic response in females currently remain unclear.
C1 [Almeida Souza, Marcos Paulo; da Silva Lima, Fernanda Macedo; Muniz, Igor Pereira; Pereira, Italo Sousa; de Oliveira Sousa, Larissa Rodrigues; Leite Galantini, Maria Poliana; dos Santos, Denisar Palmito; Figueiredo, Tiana Baqueiro; Augusto da Silva, Robson Amaro] Univ Fed Bahia, Multidisciplinary Inst Hlth, Histopathol Lab, Dept Biointegrat, Campus Anisio Teixeira, Vitoria Da Conquista, BA, Brazil.
   [Almeida Souza, Marcos Paulo] Devry Grp, Sch Ruy Barbosa, Dept Hlth, Salvador, BA, Brazil.
RP da Silva, RAA (corresponding author), Univ Fed Bahia, Multidisciplinary Inst Hlth, Histopathol Lab, Dept Biointegrat, Campus Anisio Teixeira, Vitoria Da Conquista, BA, Brazil.
EM robson.amaro@gmail.com
RI Silva, Robson A A/N-8801-2018
FU Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)
FX This study was carried out by 106 histopathology laboratory in
   Multidisciplinary Institute for Health of Federal University of Bahia.
   The Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) provide
   funds for execution this work.
CR Andersson CK, 2011, J ALLERGY CLIN IMMUN, V127, P905, DOI 10.1016/j.jaci.2011.01.022
   Antunes MA, 2010, J APPL PHYSIOL, V109, P855, DOI 10.1152/japplphysiol.00333.2010
   Asher I, 2014, INT J TUBERC LUNG D, V18, P1269, DOI 10.5588/ijtld.14.0170
   Cai YP, 2012, INT ARCH ALLERGY IMM, V158, P252, DOI 10.1159/000331437
   Card Jeffrey W, 2009, Proc Am Thorac Soc, V6, P588, DOI 10.1513/pats.200904-020RM
   Carey MA, 2007, AM J RESP CRIT CARE, V175, P126, DOI 10.1164/rccm.200509-1493OC
   Chen YP, 2015, INT J CLIN EXP MED, V8, P15403
   Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142
   Davis SR, 2012, CLIMACTERIC, V15, P419, DOI 10.3109/13697137.2012.707385
   Dimitropoulou C, 2009, LUNG, V187, P116, DOI 10.1007/s00408-008-9129-z
   Draijer C, 2016, AM J PHYSIOL-LUNG C, V310, pL166, DOI 10.1152/ajplung.00119.2015
   Ensom MHH, 2003, ANN PHARMACOTHER, V37, P1610, DOI 10.1345/aph.1D090
   Forno E, 2015, THORAX, V70, P898, DOI 10.1136/thoraxjnl-2015-207199
   Fu Liang, 2014, Ann Am Thorac Soc, V11, P939, DOI 10.1513/AnnalsATS.201402-084OC
   GIBBS CJ, 1984, THORAX, V39, P833, DOI 10.1136/thx.39.11.833
   Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023
   Holgate ST, 2006, LANCET, V368, P780, DOI 10.1016/S0140-6736(06)69288-X
   Itoga M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123210
   Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011
   Johnston RA, 2007, AM J RESP CRIT CARE, V176, P650, DOI 10.1164/rccm.200702-323OC
   Kim DI, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-227
   Ko FWS, 2007, CLIN EXP IMMUNOL, V147, P526, DOI 10.1111/j.1365-2249.2006.03315.x
   Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049
   Li H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5259
   de Oliveira APL, 2007, AM J PHYSIOL-CELL PH, V293, pC1120, DOI 10.1152/ajpcell.00286.2006
   de Oliveira APL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065674
   Ma LJ, 2007, J ENDOCRINOL, V193, P291, DOI 10.1677/JOE-06-0024
   Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x
   Matsubara S, 2008, AM J RESP CELL MOL, V38, P501, DOI 10.1165/rcmb.2007-0298OC
   Nappi RE, 2012, CLIMACTERIC, V15, P36, DOI 10.3109/13697137.2011.647840
   Newcomb DC, 2015, J ALLERGY CLIN IMMUN, V136, P1025, DOI 10.1016/j.jaci.2015.05.046
   Newcomb DC, 2013, CURR OPIN IMMUNOL, V25, P755, DOI 10.1016/j.coi.2013.08.002
   Nie HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119901
   Oliveira AP, 2010, RESP RES, V11, P2010
   Riffo-Vasquez Y, 2007, CLIN EXP ALLERGY, V37, P459, DOI 10.1111/j.1365-2222.2007.02670.x
   Robinson DS, 2009, CLIN EXP ALLERGY, V39, P1314, DOI 10.1111/j.1365-2222.2009.03301.x
   Robinson DP, 2014, J VIROL, V88, P4711, DOI 10.1128/JVI.02081-13
   ROBINSON DS, 1993, SPRINGER SEMIN IMMUN, V15, P17
   Shah S, 2012, ISRN ALLERGY, V2012
   Shah Saloni P, 2010, Iran Biomed J, V14, P41
   Takeda M, 2013, RESPIROLOGY, V18, P797, DOI 10.1111/resp.12078
   Tam A, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-24
   Townsend EA, 2012, ENDOCR REV, V33, P1, DOI 10.1210/er.2010-0031
   Valkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131594
   Viscardi RM, 2002, INFECT IMMUN, V70, P5721, DOI 10.1128/IAI.70.10.5721-5729.2002
   Wei Y, 2015, IMMUNOBIOLOGY, V220, P789, DOI 10.1016/j.imbio.2014.12.015
   Wells AD, 2014, INT IMMUNOPHARMACOL, V23, P356, DOI 10.1016/j.intimp.2014.07.014
   Yao XJ, 2014, CLIN EXP ALLERGY, V44, P765, DOI 10.1111/cea.12298
   Zein JG, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0528-y
   Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76
NR 50
TC 1
Z9 1
U1 1
U2 3
PU IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY
PI TEHRAN
PA SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL
   SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN
SN 1735-1502
EI 1735-5249
J9 IRAN J ALLERGY ASTHM
JI Iran. J. Allergy Asthma Immunol.
PD DEC
PY 2017
VL 16
IS 6
BP 525
EP 536
PG 12
WC Allergy; Immunology
SC Allergy; Immunology
GA FU8PF
UT WOS:000424115300008
PM 29338159
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Almeida, PP
   Pereira, IS
   Rodrigues, KB
   Leal, LS
   Marques, AS
   Rosa, LP
   da Silva, FC
   da Silva, RAA
AF Almeida, Palloma Porto
   Pereira, Italo Sousa
   Rodrigues, Karine Bitencourt
   Leal, Lorena Santos
   Marques, Andressa Souza
   Rosa, Luciano Pereira
   da Silva, Francine Cristina
   Augusto da Silva, Robson Amaro
TI Photodynamic therapy controls of Staphylococcus aureus intradermal
   infection in mice
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Staphylococcus aureus; Curcumin; Blue light; LED
ID MRSA IN-VITRO; BLUE-LIGHT; ESCHERICHIA-COLI; CURCUMIN; VIVO; SKIN;
   PERIODONTITIS; INACTIVATION; NEUTROPHILS; INNATE
AB Infections caused by Staphylococcus aureus lead to skin infections, as well as soft tissues and bone infections. Given the communal resistance to antibiotics developed by strains of this bacterium, photodynamic therapy emerges as a promising alternative treatment to control and cure infections. Females of the Balb/C mice were infected with 108 CFU of methicillin-resistant S. aureus (MRSA) and divided into four distinct groups: P-L-(negative control group), P+ L-(group exposed only to curcumin), P-L+ (group ex-posed only to LED incidence of 450 nm, 75 mW/cm(2), and 54 J/cm(2) for 10 min), and P+ L+ (group exposed to curcumin followed by 10 min of LED irradiation) (n = 24). The mice were euthanized 48 and 72 h after infection, and biologic materials were collected for analysis of the bacterial load, peripheral blood leukocyte counts, and draining lymph nodes cell counts. The normalization of data was checked and the ANOVA test was applied. The bacterial load in the draining lymph node of P+ L+ group was lower when compared to the control groups 72 h post infection (p < 0.0001), indicating that the LED incidence associated with curcumin controls of the staphylococci intradermal infection. The number of the total lymph node cells shows to be lower than control groups in the two availed times (p < 0.01). The histological analysis and the counting of white blood cells did not show differences among cells in the blood and in the tissue of infection. This is the first report showing that photodynamic therapy may be effective against MRSA infection in a murine model of intradermal infection.
C1 [Almeida, Palloma Porto; Pereira, Italo Sousa; Rodrigues, Karine Bitencourt; Leal, Lorena Santos; Marques, Andressa Souza; Rosa, Luciano Pereira; da Silva, Francine Cristina; Augusto da Silva, Robson Amaro] UFBA, Multidisciplinary Hlth Inst, Vitoria Da Conquista, BA, Brazil.
   [Augusto da Silva, Robson Amaro] Univ Fed Bahia, Multidisciplinary Hlth Inst, Rio de Contas St,58 Candeias, BR-45029094 Vitoria Da Conquista, BA, Brazil.
RP Rosa, LP (corresponding author), UFBA, Multidisciplinary Hlth Inst, Vitoria Da Conquista, BA, Brazil.
EM pahporto@gmail.com; italo_k9@hotmail.com; karinebitencourt23@gmail.com;
   lory.leal@hotmail.com; ddmarques23@outlook.com;
   drlucianorosa@yahoo.com.br; drfransilva@yahoo.com.br;
   robson.amaro@gmail.com
RI Silva, Robson A A/N-8801-2018
OI Almeida, Palloma Porto/0000-0002-1588-8722
FU Institutional Program of Scientific Initiation of Federal University of
   Bahia; Research Center in Optics and Photonics (CePOF)
FX This study was funded by the Institutional Program of Scientific
   Initiation of Federal University of Bahia for the Scientific Initiation
   scholarships awarded and by the Research Center in Optics and Photonics
   (CePOF) for the equipment to the development of this work.
CR de Sousa NTA, 2015, PHOTOMED LASER SURG, V33, P278, DOI 10.1089/pho.2014.3854
   Alves E, 2008, J IND MICROBIOL BIOT, V35, P1447, DOI 10.1007/s10295-008-0446-2
   Silva LAB, 2012, J ENDODONT, V38, P360, DOI 10.1016/j.joen.2011.12.023
   Broker BM, 2014, INT J MED MICROBIOL, V304, P204, DOI 10.1016/j.ijmm.2013.11.008
   Bruzell EM, 2005, PHOTOCH PHOTOBIO SCI, V4, P523, DOI 10.1039/b503397g
   Bumah VV, 2015, LASER SURG MED, V47, P595, DOI 10.1002/lsm.22385
   Bumah VV, 2015, LASER SURG MED, V47, P266, DOI 10.1002/lsm.22327
   Bumah VV, 2013, PHOTOMED LASER SURG, V31, P547, DOI 10.1089/pho.2012.3461
   Dai TH, 2013, PHOTOMED LASER SURG, V31, P531, DOI 10.1089/pho.2012.3365
   dos Reis JA, 2014, LASER MED SCI, V29, P789, DOI 10.1007/s10103-013-1422-2
   Elmore SA, 2006, TOXICOL PATHOL, V34, P425, DOI 10.1080/01926230600964722
   Enwemeka CS, 2013, PHOTOMED LASER SURG, V31, P509, DOI 10.1089/pho.2013.9871
   Enwemeka CS, 2009, PHOTOMED LASER SURG, V27, P221, DOI 10.1089/pho.2008.2413
   Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667
   Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713
   Grinholc M, 2015, APPL MICROBIOL BIOT, V99, P4031, DOI 10.1007/s00253-015-6539-8
   Hajim KI, 2010, LASER MED SCI, V25, P743, DOI 10.1007/s10103-010-0803-z
   Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a
   Hermida MDR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-450
   Krejsgaard T, 2014, BLOOD, V124, P761, DOI 10.1182/blood-2014-01-551184
   Krishna S, 2012, SEMIN IMMUNOPATHOL, V34, P261, DOI 10.1007/s00281-011-0292-6
   Lambrechts SAG, 2005, PHOTOCH PHOTOBIO SCI, V4, P503, DOI 10.1039/b502125a
   Martins CVB, 2009, J ANTIMICROB CHEMOTH, V63, P337, DOI 10.1093/jac/dkn488
   McCaig LF, 2006, EMERG INFECT DIS, V12, P1715, DOI 10.3201/eid1211.060190
   PANLILIO AL, 1992, INFECT CONT HOSP EP, V13, P582
   Prates RA, 2011, PHOTOMED LASER SURG, V29, P835, DOI 10.1089/pho.2010.2984
   Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3
   Rosa LP, 2015, ARCH ORAL BIOL, V60, P675, DOI 10.1016/j.archoralbio.2015.02.010
   Senthilkumar K, 2015, INDIAN PEDIATR, V52, P31, DOI 10.1007/s13312-015-0562-9
   Sutton S., 2006, PMF NEWSL, V12, P3
   Zolfaghari PS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-27
NR 31
TC 13
Z9 13
U1 0
U2 7
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
EI 1435-604X
J9 LASER MED SCI
JI Lasers Med. Sci.
PD AUG
PY 2017
VL 32
IS 6
BP 1337
EP 1342
DI 10.1007/s10103-017-2247-1
PG 6
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA FC1MK
UT WOS:000406601200012
PM 28646389
DA 2020-12-08
ER

PT J
AU Kaneto, CM
   Nascimento, JS
   Moreira, MCR
   Ludovico, ND
   Santana, AP
   Silva, RAA
   Silva-Jardim, I
   Santos, JL
   Sousa, SMB
   Lima, PSP
AF Kaneto, C. M.
   Nascimento, J. S.
   Moreira, M. C. R.
   Ludovico, N. D.
   Santana, A. P.
   Silva, R. A. A.
   Silva-Jardim, I.
   Santos, J. L.
   Sousa, S. M. B.
   Lima, P. S. P.
TI MicroRNA profiling identifies miR-7-5p and miR-26b-5p as differentially
   expressed in hypertensive patients with left ventricular hypertrophy
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Cardiovascular disease; Hypertension; Left ventricular hypertrophy;
   microRNAs
ID GROWTH-FACTOR RECEPTOR; CIRCULATING MICRORNAS; HEART-FAILURE;
   MONONUCLEAR-CELLS; FIBROSIS; CANCER; CARDIOMYOPATHY; BIOMARKERS;
   PATHWAY; MICE
AB Recent evidence suggests that cell-derived circulating miRNAs may serve as biomarkers of cardiovascular diseases. However, a few studies have investigated the potential of circulating miRNAs as biomarkers for left ventricular hypertrophy (LVH). In this study, we aimed to characterize the miRNA profiles that could distinguish hypertensive patients with LHV, hypertensive patients without LVH and control subjects, and identify potential miRNAs as biomarkers of LVH. LVH was defined by left ventricular mass indexed to body surface area 4125 g/m(2) in men and 4110 g/m(2) in women and patients were classified as hypertensive when presenting a systolic blood pressure of 140 mmHg or more, or a diastolic blood pressure of 90 mmHg or more. We employed miRNA PCR array to screen serum miRNAs profiles of patients with LVH, essential hypertension and healthy subjects. We identified 75 differentially expressed miRNAs, including 49 upregulated miRNAs and 26 downregulated miRNAs between LVH and control patients. We chose 2 miRNAs with significant differences for further testing in 59 patients. RT-PCR analysis of serum samples confirmed that miR-7-5p and miR-26b-5p were upregulated in the serum of LVH hypertensive patients compared with healthy subjects. Our findings suggest that these miRNAs may play a role in the pathogenesis of hypertensive LVH and may represent novel biomarkers for this disease.
C1 [Kaneto, C. M.; Silva-Jardim, I.; Santos, J. L.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil.
   [Nascimento, J. S.; Moreira, M. C. R.; Ludovico, N. D.] Univ Estadual Santa Cruz, Dept Ciencias Saude, Ilheus, BA, Brazil.
   [Santana, A. P.; Sousa, S. M. B.; Lima, P. S. P.] Univ Estadual Sudoeste Bahia, Dept Ciencias Nat, Vitoria Da Conquista, BA, Brazil.
   [Silva, R. A. A.] Univ Estadual Sudoeste Bahia, Inst Multidisciplinar Saude, Vitoria Da Conquista, BA, Brazil.
RP Kaneto, CM (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil.
EM cmkaneto@uesc.br
RI Silva, Robson A A/N-8801-2018; Avaliacao, PPGCS/ABF-2467-2020
FU FAPESB (Fundacao de Amparo a Pesquisa do Estado da Bahia); CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)National
   Council for Scientific and Technological Development (CNPq); UESC
   (Universidade Estadual de Santa Cruz)
FX This work was supported by FAPESB (Fundacao de Amparo a Pesquisa do
   Estado da Bahia), CNPq (Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico), and UESC (Universidade Estadual de Santa Cruz).
CR Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2
   Bagnall RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044744
   Chen JH, 2012, J MOL CELL CARDIOL, V52, P949, DOI 10.1016/j.yjmcc.2012.01.012
   Chen ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105702
   Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76
   De Oliveira SA, 2012, CYTOTHERAPY, V14, P339, DOI 10.3109/14653249.2011.637668
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Fang L, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0672-0
   He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379
   Huang XT, 2015, EXP THER MED, V10, P921, DOI 10.3892/etm.2015.2645
   Kahan T, 2005, HEART, V91, P250, DOI 10.1136/hrt.2004.042473
   Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639
   Kontaraki JE, 2015, J AM SOC HYPERTENS, V9, P802, DOI 10.1016/j.jash.2015.07.013
   Kumarswamy R, 2013, CIRC RES, V113, P676, DOI 10.1161/CIRCRESAHA.113.300226
   Kupari M, 2005, EUR HEART J, V26, P1790, DOI 10.1093/eurheartj/ehi290
   Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147
   Martinelli NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093271
   Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013
   Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105
   Miyamoto K, 2016, BRIT J CANCER, V115, P354, DOI 10.1038/bjc.2016.179
   Ovchinnikova ES, 2016, EUR J HEART FAIL, V18, P414, DOI 10.1002/ejhf.332
   Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255
   Portnoy V, 2011, WIRES RNA, V2, P748, DOI 10.1002/wrna.90
   Roncarati R, 2014, J AM COLL CARDIOL, V63, P920, DOI 10.1016/j.jacc.2013.09.041
   Saiselet M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2082-3
   Schillaci G, 2000, HYPERTENSION, V35, P580, DOI 10.1161/01.HYP.35.2.580
   Souza BSD, 2014, INT J EXP PATHOL, V95, P321, DOI 10.1111/iep.12089
   Leal MMT, 2014, NEUROCHEM RES, V39, P259, DOI 10.1007/s11064-013-1217-7
   van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864
   Wang W, 2013, NEOPLASMA, V60, P274, DOI 10.4149/neo_2013_036
   Wang Y, 2016, TUMOR BIOL, V37, P10965, DOI 10.1007/s13277-016-4964-7
   Wang Y, 2016, ONCOTARGET, V7, P24383, DOI 10.18632/oncotarget.8328
   Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200
   Wu DC, 2016, J MOL MED, V94, P875, DOI 10.1007/s00109-016-1426-z
   Xue H, 2008, CLIN SCI, V114, P131, DOI 10.1042/CS20070109
NR 35
TC 9
Z9 9
U1 0
U2 2
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 2017
VL 50
IS 12
AR e6211
DI 10.1590/1414-431X20176211
PG 9
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA FK0QP
UT WOS:000413184900001
PM 29069223
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Silveira, EA
   Ribeiro, IS
   Amorim, MS
   Rocha, DV
   Coutinho, HS
   de Freitas, LM
   Tomazi, L
   da Silva, RAA
AF da Silveira, Eliezer A.
   Ribeiro, Israel S.
   Amorim, Miguel S.
   Rocha, Dalva V.
   Coutinho, Helder S.
   de Freitas, Leandro M.
   Tomazi, Laize
   da Silva, Robson A. A.
TI Correlation between infection rate of triatominies and Chagas Disease in
   Southwest of Bahia, Brazil: a warning sign?
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE Infection; Chagas disease; Trypanosoma cruzi; vector
ID HEMIPTERA REDUVIIDAE TRIATOMINAE; TRYPANOSOMA-CRUZI; STATE; CEARA;
   EPIDEMIOLOGY
AB Chagas disease, caused by the Trypanosoma cruzi, has a wide distribution in South America, and its main method of control is the elimination of triatomines. It is presented here the geographic distribution and the rate of natural infection by T. cruzi of triatomines collected and evaluated from 2008 to 2013 in southwest of Bahia. Triatomines were captured in the intradomiciliary and peridomiciliary areas of five cities located in the southwest of Bahia state, identified, and analyzed for the presence of trypanosomatids in their feces. During the study period the number of patients suspected for acute Chagas disease was recovered from the Notifiable Diseases Information System (SINAN). 8966 triatomines were captured and identified as belonging to eight species. Twenty-six presented themselves infected, being Triatoma sordida the most abundant and with the highest percentage of infection by T. cruzi. Tremedal was the city with the highest number of cases of acute Chagas' disease reported to SINAN. All cities showed triatomines infected with T. cruzi, so there is considerable risk of vectorial transmission of Chagas disease in the southwestern Bahia state, evidencing the need for vector transmission control programs and preventive surveillance measures.
C1 [da Silveira, Eliezer A.; Amorim, Miguel S.; Rocha, Dalva V.] Secretaria Saude Estado Bahia, Diretoria Reg Saude 20a, Vigilancia Epidemiol, Controle Doencas Endem, Rua Joao Pereira S-N, BR-45000115 Vitoria Da Conquista, BA, Brazil.
   [Ribeiro, Israel S.; de Freitas, Leandro M.; Tomazi, Laize; da Silva, Robson A. A.] Univ Fed Bahia, Inst Multidisciplinar Saude, Campus Anisio Teixeira,Rua Rio de Contas 58, BR-45029094 Vitoria Da Conquista, BA, Brazil.
   [Coutinho, Helder S.] Secretaria Saude Estado Bahia, Vigilancia Epidemiol, Programa Controle Doenca Chagas, Ave ACM S-N, BR-41820300 Salvador, BA, Brazil.
RP da Silva, RAA (corresponding author), Univ Fed Bahia, Inst Multidisciplinar Saude, Campus Anisio Teixeira,Rua Rio de Contas 58, BR-45029094 Vitoria Da Conquista, BA, Brazil.
EM robson.amaro@gmail.com
RI Silva, Robson A A/N-8801-2018; Freitas, Leandro/AAK-3005-2020
OI Freitas, Leandro/0000-0003-4327-2922; Tomazi, Laize/0000-0003-0977-8508;
   Souza Ribeiro, Israel/0000-0002-1262-1387
FU Ministry of Health of Brazil
FX We thank all the Chagas Disease Control Program staff attached to the
   20th Regional Board of Health and the Bahia State Health Secretariat
   involved in the collection and transport of triatomines. We also thank
   the municipalities for which data were reported through the Notifiable
   Diseases Information System (SINAN) and also to the financial support
   granted by Ministry of Health of Brazil.
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
   Araujo RF, 2014, REV SOC BRAS MED TRO, V47, P513, DOI 10.1590/0037-8682-0219-2013
   Silva MBA, 2012, REV SOC BRAS MED TRO, V45, P60, DOI 10.1590/S0037-86822012000100012
   ASSIS GFM, 2007, REV SOC BRAS MED TRO, V40, P391
   BARRETT TV, 1979, T ROY SOC TROP MED H, V73, P703, DOI 10.1016/0035-9203(79)90025-7
   Belisario CJ, 2013, REV SOC BRAS MED TRO, V46, P779, DOI 10.1590/0037-8682-1712-2013
   CAMARGO ME, 1984, REV I MED TROP, V26, P192, DOI 10.1590/S0036-46651984000400003
   Caranha L, 2006, REV SOC BRAS MED TRO, V39, P347, DOI 10.1590/S0037-86822006000400006
   de Carvalho EOC, 2011, REV SOC BRAS MED TRO, V44, P703, DOI 10.1590/S0037-86822011000600010
   Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006
   Pessoa GCD, 2014, REV SOC BRAS MED TRO, V47, P426, DOI 10.1590/0037-8682-0129-2014
   de Carvalho ME, 2011, REV SOC BRAS MED TRO, V44, P85, DOI 10.1590/S0037-86822011000800013
   de Oliveira AWS, 2007, REV SOC BRAS MED TRO, V40, P204, DOI 10.1590/S0037-86822007000200011
   Dias J C, 2000, Cad Saude Publica, V16 Suppl 2, P13, DOI 10.1590/S0102-311X2000000800003
   Diotaiuti Lileia, 2009, P24
   Forattini O P, 1981, Rev Saude Publica, V15, P113
   Forattini O P, 1979, Rev Saude Publica, V13, P220, DOI 10.1590/S0034-89101979000300007
   Freitas SPC, 2005, REV SAUDE PUBL, V39, P27, DOI 10.1590/s0034-89102005000100004
   Freitas SPC, 2004, REV SAUDE PUBL, V38, P578, DOI 10.1590/S0034-89102004000400015
   Frias-Lasserre D, 2010, NEOTROP ENTOMOL, V39, P572, DOI 10.1590/S1519-566X2010000400017
   Galvao C, 2003, ZOOTAXA, V202, P1, DOI DOI 10.11646/Z00TAXA.202.1.1
   Gurgel-Goncalves R, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/705326
   Guzman-Marin E, 1990, REV BIOMED, V1, P144
   Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x
   Leite GR, 2007, CHECK LIST, P147, DOI DOI 10.15560/3.2.147
   Marcal JR O, 2004, CAMINHOS GEOGRAFIA, V3, P50
   Marin-Neto JA, 2009, REV ESP CARDIOL, V62, P1211, DOI 10.1016/S0300-8932(09)73071-4
   Mota-Sanchez J, 2009, SALUD PUBLICA MEXICO, V51, pS463, DOI 10.1590/s0036-36342009000900012
   Ostermayer AL, 2011, REV SOC BRAS MED TRO, V44, P108, DOI 10.1590/S0037-86822011000800015
   PERLOWAGORASZUMLEWICZ A, 1994, MEM I OSWALDO CRUZ, V89, P603, DOI 10.1590/S0074-02761994000400018
   Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002
   Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
   Ribeiro AR, 2014, REV SAUDE PUBL, V48, P296, DOI 10.1590/S0034-8910.2014048004719
   Santana KDO, 2011, GEOSPATIAL HEALTH, V5, P199
   Sarquis O, 2004, MEM I OSWALDO CRUZ, V99, P263, DOI 10.1590/S0074-02762004000300004
   Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011
   Sessa Paulo Augusto, 2002, Cad. Saúde Pública, V18, P1765, DOI 10.1590/S0102-311X2002000600031
   SiLVEIRA AC, 2003, GUIA AMOSTRAGEM APLI
   Silveira AC, 2002, CONTROLE DOENCA CHAG
   Silveira AC, 2006, SALVADOR SECRETARIA
   Silveira AC, 2011, REV SOC BRAS MED TRO, V44, P52, DOI 10.1590/S0037-86822011000800009
   Dias FBS, 2008, MEM I OSWALDO CRUZ, V103, P824, DOI 10.1590/S0074-02762008000800014
   Villela Marcos M., 2005, Cad. Saúde Pública, V21, P878, DOI 10.1590/S0102-311X2005000300022
   WHO, 1991, WHO TECH REP SER, V811, P1
NR 44
TC 2
Z9 2
U1 0
U2 3
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD NOV
PY 2016
VL 88
IS 3
SU S
BP 1941
EP 1951
DI 10.1590/0001-3765201620150744
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EF3BD
UT WOS:000390198500030
PM 27411071
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Silva, JR
   Ferreira, LFAA
   Oliveira, PVS
   Nunes, IV
   Pereira, IS
   Timenetsky, J
   Marques, LM
   Figueiredo, TB
   Silva, RAA
AF Silva, Jamile R.
   Ferreira, Licio F. A. A.
   Oliveira, Percillia V. S.
   Nunes, Ivaneia V.
   Pereira, Italo S.
   Timenetsky, Jorge
   Marques, Lucas M.
   Figueiredo, Tiana B.
   Silva, Robson A. A.
TI Intra-uterine experimental infection by Ureaplasma diversum induces
   TNF-alpha mediated womb inflammation in mice
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE Mycoplasma; uterus; Ureaplasma; mice
ID NECROSIS-FACTOR-ALPHA; ESTROUS-CYCLE; UREALYTICUM; DISEASE; MYCOPLASMA;
   CATTLE; MODEL; LYMPHOCYTES; MACROPHAGES; NEUTROPHILS
AB Ureaplasma diversum is an opportunistic pathogen associated with uterine inflammation, impaired embryo implantation, infertility, abortions, premature birth of calves and neonatal pneumonia in cattle. It has been suggested that the intra-uterine infection by Ureaplasma diversum can cause vascular changes that hinder the success of pregnancy. Thus, the aim of this study was to evaluate the changes of intrauterine site of A/J mice in estrus or proestrus phase inoculated with Ureaplasma diversum. The infection was monitored at 24, 48 and 72 hours by the PCR methodology to detect the Ureaplasma in the inoculation site and the profile of circulating blood cells. Morphological changes, intensity of inflammation and the production of cytokines were compared. The infected mice showed local inflammation through the production of IFN-gamma and TNF-alpha. Ureaplasma diversum infections in the reproductive tract of studied mice seemed to be associated with the production of pro-inflammatory cytokines in uterine parenchyma. The levels of TNF-a of infected mice were dependent on the bacterial load of inoculated Ureaplasma. Uterine experimental infections by Ureaplasma diversum have not been mentioned yet and herein we presented the first report of an intrauterine infection model in mice.
C1 [Silva, Jamile R.; Ferreira, Licio F. A. A.; Oliveira, Percillia V. S.; Nunes, Ivaneia V.; Pereira, Italo S.; Marques, Lucas M.; Figueiredo, Tiana B.; Silva, Robson A. A.] Univ Fed Bahia, Lab Histopatol & Parasitol, Inst Multidisciplinar Saude, Campus Anisio Teixeira,Rua Rio Contas,Quadra 17, BR-45029094 Vitoria Da Conquista, BA, Brazil.
   [Timenetsky, Jorge] Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed 2, Av Prof Lineu Prestes 1374, BR-05508000 Sao Paulo, SP, Brazil.
RP Silva, RAA (corresponding author), Univ Fed Bahia, Lab Histopatol & Parasitol, Inst Multidisciplinar Saude, Campus Anisio Teixeira,Rua Rio Contas,Quadra 17, BR-45029094 Vitoria Da Conquista, BA, Brazil.
EM robson.amaro@gmail.com
RI Silva, Robson A A/N-8801-2018
CR Allam AB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-101
   Argue B, 2013, AUST VET J, V91, P99, DOI 10.1111/avj.12009
   BUZUNHANI M., 2011, BMC RES NOTES, V4, P1
   Cardoso MV, 2000, VET MICROBIOL, V72, P241, DOI 10.1016/S0378-1135(99)00203-5
   Chan G, 2005, J PATHOL, V207, P462, DOI 10.1002/path.1849
   Chandiramani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052412
   Chelmonska-Soyta A, 1994, CAN J VET RES, V58, P275
   Estrada-Gutierrez G, 2010, INFECT IMMUN, V78, P4792, DOI 10.1128/IAI.00522-10
   Famuyide ME, 2009, PEDIATR RES, V66, P162, DOI 10.1203/PDR.0b013e3181aabd66
   Gambarini ML, 2009, TROP ANIM HEALTH PRO, V41, P1421, DOI 10.1007/s11250-009-9330-y
   Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619
   Gloerich M, 2010, MOL CELL BIOL, V30, P5421, DOI 10.1128/MCB.00463-10
   HAIMOVICI F, 1991, BIOL REPROD, V44, P69, DOI 10.1095/biolreprod44.1.69
   Honma Y, 2007, PEDIATR INT, V49, P479, DOI 10.1111/j.1442-200X.2007.02391.x
   Jiemtaweeboon S, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-79
   KIM JJ, 1994, INFECT IMMUN, V62, P1528, DOI 10.1128/IAI.62.5.1528-1533.1994
   Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1
   Kobayashi Y, 2013, ARCH IMMUNOL THER EX, V61, P187, DOI 10.1007/s00005-013-0218-1
   KREPLIN CMA, 1989, CAN VET J, V30, P435
   Kumar A, 2014, J CLIN PERIODONTOL, V41, P357, DOI 10.1111/jcpe.12226
   Manimtim WM, 2001, INFECT IMMUN, V69, P3906, DOI 10.1128/IAI.69.6.3906-3915.2001
   Marchioni RM, 2013, WORLD J GASTROENTERO, V19, P2591, DOI 10.3748/wjg.v19.i17.2591
   Marenzoni ML, 2013, VET RES COMMUN, V37, P311, DOI 10.1007/s11259-013-9578-6
   MARQUES LM, 2013, VET MICROBIOL, V31, P394
   Marques LM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-83
   McGowin CL, 2013, J INFECT DIS, V207, P1857, DOI 10.1093/infdis/jit101
   Miller CM, 2009, INT J PARASITOL, V39, P23, DOI 10.1016/j.ijpara.2008.08.002
   MILLER R, 1994, VET CLIN N AM-FOOD A, V10, P479, DOI 10.1016/S0749-0720(15)30533-8
   MURRAY RD, 1991, J VET MED A, V38, P660, DOI 10.1111/j.1439-0442.1991.tb01062.x
   OHLSSON A, 1993, CLIN INFECT DIS, V17, pS144, DOI 10.1093/clinids/17.Supplement_1.S144
   Peng Y, 2013, FOLIA MICROBIOL, V58, P593, DOI 10.1007/s12223-013-0238-6
   Reyes L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-9
   Robinson JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062746
   Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1
   RUHNKE HL, 1984, THERIOGENOLOGY, V21, P295, DOI 10.1016/0093-691X(84)90415-1
   RUHNKE HL, 1994, MYCOPLASMOSIS ANIMAL, P141
   SAADA AB, 1988, ZBL BAKT-INT J MED M, V269, P160
   Sasaki S, 2009, BIOCHEM BIOPH RES CO, V382, P35, DOI 10.1016/j.bbrc.2009.02.112
   Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653
   SMITH DGE, 1993, J BACTERIOL, V175, P3253, DOI 10.1128/jb.175.11.3253-3258.1993
   TAYLORRO.D, 1967, ANN NY ACAD SCI, V143, P517, DOI 10.1111/j.1749-6632.1967.tb27697.x
   Tegtmeier C, 1999, J VET MED B, V46, P693, DOI 10.1046/j.1439-0450.1999.00301.x
   Thomas A, 2002, VET REC, V151, P472, DOI 10.1136/vr.151.16.472
   Versalovic J, 2011, MANUAL CLIN MICROBIO
   Viscardi RM, 2002, INFECT IMMUN, V70, P5721, DOI 10.1128/IAI.70.10.5721-5729.2002
   Viscardi RM, 2010, CLIN PERINATOL, V37, P393, DOI 10.1016/j.clp.2009.12.003
   Viscardi RM, 2014, ARCH DIS CHILD-FETAL, V99, pF87, DOI 10.1136/archdischild-2012-303351
   von Chamier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044047
   Waites KB, 2012, J MOL DIAGN, V14, P437, DOI 10.1016/j.jmoldx.2012.06.001
   Wang X, 2015, 3RD INTERNATIONAL CONFERENCE ON ADVANCED COMPOSITE MATERIALS AND MANUFACTURING ENGINEERING (CMME 2015), P10
   Yui J, 1996, BIOL REPROD, V55, P400, DOI 10.1095/biolreprod55.2.400
   Zhu GX, 2011, CAN J MICROBIOL, V57, P987, DOI [10.1139/W11-098, 10.1139/w11-098]
NR 52
TC 7
Z9 7
U1 0
U2 10
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD MAY
PY 2016
VL 88
IS 1
SU S
BP 643
EP 652
DI 10.1590/0001-3765201620150244
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO9JI
UT WOS:000378102100019
PM 26871498
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU de Oliveira, THC
   Amorin, AT
   Rezende, IS
   Barbosa, MS
   Martins, HB
   Brito, AKP
   Andrade, EF
   Goncalves, GKN
   Campos, GB
   Silva, RAA
   Timenetsky, J
   Marques, LM
AF Caldeira de Oliveira, Thiago Henrique
   Amorin, Aline Teixeira
   Rezende, Izadora Souza
   Barbosa, Maysa Santos
   Martins, Hellen Braga
   Pereira Brito, Anne Karoline
   Andrade, Ewerton Ferraz
   Neves Goncalves, Gleisy Kelly
   Campos, Guilherme Barreto
   Augusto Silva, Robson Amaro
   Timenetsky, Jorge
   Marques, Lucas Miranda
TI Sepsis Induced by Staphylococcus aureus: Participation of Biomarkers in
   a Murine Model
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE Biological Markers; Sepsis; Staphylococcus aureus
ID C-REACTIVE PROTEIN; RAPID DIAGNOSIS; SEPTIC SHOCK; PROCALCITONIN;
   INFECTION; PATHOPHYSIOLOGY; EMERGENCY; MARKER; INTERLEUKIN-6;
   MACROPHAGES
AB Background: This study aimed to evaluate the role of biomarkers in the pathophysiological process induced by a Staphylococcus aureus strain obtained in a hospital environment. For this, we intraperitoneally inoculated groups of male BALB/c mice with S. aureus, using a clinical isolate (CI) of S. aureus.
   Material/Methods: Mice were divided into groups according to time of euthanasia (24, 48, 72, 96, 120, 144, and 168 hours of infection). After being euthanized, blood samples were collected for quantification of microorganisms and leukocytes, as well as measurement of biomarkers of tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), C-reactive protein (CRP), and Procalcitonin (PCT) by ELISA. Heart, kidneys, and lungs were removed for histopathological analysis, assessment of biomarkers of tissue expression by RT-PCR (polymerase chain reaction with reverse transcriptase), and quantification of microorganisms by real-time quantitative PCR (real-time PCR).
   Results: The animals infected at between 120 hours and 168 hours had the highest blood levels of S. aureus. We observed that infection promoted increases in the levels of circulating neutrophils and monocytes. However, there was a reduction of circulating neutrophils and monocytes after 96 hours of infection. The infected mice also had increased levels of blood lymphocytes. In this model of infection with S. aureus, IL-6, CRP, and PCT demonstrated greater fidelity as markers of infection, since serum levels were elevated and lowered along with the number of circulating neutrophils and monocytes after resolution of the infection. The lungs showed hyperemia, with enlargement of the alveolar septa. On the other hand, infection with S. aureus did not promote visible change in histological tissue in the heart and kidneys.
   Conclusions: In this model of infection with S. aureus, IL-6, CRP, and PCT demonstrated greater fidelity as markers of infection, since serum levels were elevated and lowered along with the number of circulating neutrophils and monocytes after resolution of the infection. We believe our results may provide a better understanding of the pathophysiology, as well as aid in the search for a more reliable method of diagnosis.
C1 [Caldeira de Oliveira, Thiago Henrique; Amorin, Aline Teixeira; Rezende, Izadora Souza; Barbosa, Maysa Santos; Martins, Hellen Braga; Pereira Brito, Anne Karoline; Andrade, Ewerton Ferraz; Neves Goncalves, Gleisy Kelly; Augusto Silva, Robson Amaro; Marques, Lucas Miranda] Fed Univ Bahia Vitoria Conquista, Multidisciplinary Inst Hlth, Vitoria Da Conquista, BA, Brazil.
   [Campos, Guilherme Barreto; Timenetsky, Jorge] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil.
RP Marques, LM (corresponding author), Fed Univ Bahia Vitoria Conquista, Multidisciplinary Inst Hlth, Vitoria Da Conquista, BA, Brazil.
EM lucasm@ufba.br
RI Oliveira, Thiago H C/U-7868-2017; Silva, Robson A A/N-8801-2018;
   TEIXEIRA AMORIM, ALINE/H-3026-2016
OI TEIXEIRA AMORIM, ALINE/0000-0003-2597-8665
FU FAPESB [BOL0824/2011]; Programa de apoio a pesquisadores emergentes da
   UFBA [PRODOC 02/2011]
FX This study was supported by FAPESB (BOL0824/2011) and Programa de apoio
   a pesquisadores emergentes da UFBA (PRODOC 02/2011)
CR Al Achkar M, 2012, AM J CASE REP, V13, P26, DOI 10.12659/AJCR.882588
   Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466
   Biju PG, 2012, SHOCK, V38, P170, DOI 10.1097/SHK.0b013e31825b2db3
   Bloos F, 2014, VIRULENCE, V5, P154, DOI 10.4161/viru.27393
   BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457
   Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3
   Cabrera-Perez J, 2014, J LEUKOC BIOL
   Campos GB, 2012, NEW MICROBIOL, V35, P183
   Chan YL, 2004, CRIT CARE, V8, pR12, DOI 10.1186/cc2396
   Chiesa C, 2003, CLIN CHEM, V49, P60, DOI 10.1373/49.1.60
   Dong Q, 1996, J IMMUNOL, V156, P4815
   Ferguson NR, 1999, INTENS CARE MED, V25, P106, DOI 10.1007/s001340050795
   Gentili A, 2006, MED SCI MONITOR, V12, pLE11
   Goetghebeur M, 2007, CAN J INFECT DIS MED, V18, P27, DOI 10.1155/2007/253947
   Grandel U, 2000, CIRCULATION, V102, P2758, DOI 10.1161/01.CIR.102.22.2758
   Gullo A, 2006, CRIT CARE CLIN, V22, P489, DOI 10.1016/j.ccc.2006.03.006
   Gutierrez J, 2009, MED SCI MONITOR, V15, pCR499
   Hausfater P, 2002, CLIN INFECT DIS, V34, P895, DOI 10.1086/339198
   Hotchkiss RS, 2005, CLIN INFECT DIS, V41, pS465, DOI 10.1086/431998
   Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
   Jincharadze N, 2006, Georgian Med News, P87
   Kotoula A, 2009, UROLOGY, V73, P782, DOI 10.1016/j.urology.2008.10.042
   Kubler A, 2006, MED SCI MONITOR, V12, pCR107
   Lausevic Z, 2010, VOJNOSANIT PREGL, V67, P893, DOI 10.2298/VSP1011893L
   Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE
   Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807
   LIESCHKE GJ, 1994, BLOOD, V84, P1737
   Martin G, 2009, CRIT CARE, V13, DOI 10.1186/cc7936
   Mehanic Snjezana, 2013, Mater Sociomed, V25, P277, DOI 10.5455/msm.2013.25.277-281
   Morgenthaler NG, 2003, HORM METAB RES, V35, P290
   MOSCOVITZ H, 1994, CRIT CARE MED, V22, P1102, DOI 10.1097/00003246-199407000-00009
   Naber CK, 2009, CLIN INFECT DIS, V48, pS231, DOI 10.1086/598189
   Nelson GE, 2015, BIOMED RES INT, V2114, P264
   Oberholzer A, 2001, IMMUNOL LETT, V75, P221, DOI 10.1016/S0165-2478(00)00307-2
   Ozturk E, 2008, PEDIATR SURG INT, V24, P899, DOI 10.1007/s00383-008-2184-y
   Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872
   Azevedo LCP, 2013, SHOCK, V39, P1, DOI 10.1097/SHK.0b013e31828fad4a
   Povoa P, 2002, INTENS CARE MED, V28, P235, DOI 10.1007/s00134-002-1209-6
   Reinhart K, 2012, CLIN MICROBIOL REV, V25, P609, DOI 10.1128/CMR.00016-12
   Ribas VJ, 2011, IEEE ENG MED BIO, P100, DOI 10.1109/IEMBS.2011.6089906
   RUNCIE C, 1990, WORLD J SURG, V14, P196, DOI 10.1007/BF01664873
   Sahm DF, 1999, CLIN INFECT DIS, V29, P259, DOI 10.1086/520195
   Silman NJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13137
   Thomas LC, 2007, J MICROBIOL METH, V68, P296, DOI 10.1016/j.mimet.2006.09.003
   Ventetuolo CE, 2008, CLIN CHEST MED, V29, P591, DOI 10.1016/j.ccm.2008.07.001
   Verdrengh M, 2000, ARTHRITIS RHEUM, V43, P2276, DOI 10.1002/1529-0131(200010)43:10<2276::AID-ANR15>3.0.CO;2-C
   Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991
   Yi C, 2009, INFLAMM RES, V58, P855, DOI 10.1007/s00011-009-0056-0
NR 48
TC 5
Z9 5
U1 0
U2 3
PU INT SCIENTIFIC LITERATURE, INC
PI SMITHTOWN
PA 361 FOREST LANE, SMITHTOWN, NY 11787 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD JAN 29
PY 2015
VL 21
BP 345
EP 355
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CE9AA
UT WOS:000352134400001
PM 25630550
OA Green Published
DA 2020-12-08
ER

PT J
AU Amorim, MM
   Tomazi, L
   da Silva, RAA
   Gestinari, RD
   Figueiredo, TB
AF Amorim, Maise Mendonca
   Tomazi, Laize
   Augusto da Silva, Robson Amaro
   Gestinari, Raquel de Souza
   Figueiredo, Tiana Baqueiro
TI EVALUATION OF HOUSING AND HEALTH CONDITIONS OF BOQUEIRAO AFRO DESCENDANT
   COMMUNITY, STATE OF BAHIA, BRAZIL
SO BIOSCIENCE JOURNAL
LA Portuguese
DT Article
DE Afro descendant community; Parasitic diseases; Protozoosis; Helminthic
   infections
ID CHILDREN
AB The Boqueirao is an afro descendant community located in Vitoria da Conquista, Bahia, Brazil formed by about 500 individuals. This community has an only dam, where animals have free access, used frequently for washing clothes and water collection for domestic use. The water supply is precarious, as well as the basic sanitation, since it does not exist canalized water and sanitary exhaustion. It results in the ousting of dejections in the dam and ground, compromising the quality of the consumed water. These factors associated to limited access of the population health services become these individuals vulnerable to parasitic infections. The aim of this work is register the habitation and health conditions of the Boqueirao community. The sample was composed by 467 individuals that answered a questionnaire about their housing and health conditions. Of these, 404 had been submitted to fecal exam for the diagnosis of parasitic diseases. The population is formed predominantly by young or adult, agricultural worker, and most of houses have not canalized water and bathroom. Most of population uses only the public system of health and the high blood pressure was the most reported preexisting disease. In relation to the intestinal parasitisms, the protozoan infections were more prevalent than helminthic infections. The precarious conditions of habitation, water supply and basic sanitation reflect the social and economic population profiles and the inefficiency of health public politics for the community that explains the data found regarding the prevalence of chronic and parasitic diseases.
C1 [Amorim, Maise Mendonca] Univ Fed Bahia UFBA, Vitoria Da Conquista, BA, Brazil.
   [Tomazi, Laize; Augusto da Silva, Robson Amaro; Gestinari, Raquel de Souza; Figueiredo, Tiana Baqueiro] UFBA, Vitoria Da Conquista, BA, Brazil.
RP Amorim, MM (corresponding author), Univ Fed Bahia UFBA, Vitoria Da Conquista, BA, Brazil.
EM maimendonca@hotmail.com
RI Silva, Robson A A/N-8801-2018
CR Alves Jair Rodrigues, 2003, Cad. Saúde Pública, V19, P667, DOI 10.1590/S0102-311X2003000200034
   AMOROZO M C D M, 1988, Boletim do Museu Paraense Emilio Goeldi Serie Botanica, V4, P47
   BANDEIRA M. L., 2002, QUILOMBOS IDENTIDADE, P213
   BATISTA L. E., 2005, MORTALIDADE POPULACA, P237
   Begossi A., 1993, Journal of Ethnobiology, V13, P233
   Biscegli Terezinha Soares, 2009, Rev. paul. pediatr., V27, P289, DOI 10.1590/S0103-05822009000300009
   BRASIL, 2005, PERFIL COMUNIDADES Q
   Cabral-Miranda G., 2010, Revista de Patologia Tropical, V39, P48
   CASTINEIRAS T. M. P. P., 2000, INFECCOES HELMINTOS
   Cooper RS, 1999, SCI AM, V280, P56, DOI 10.1038/scientificamerican0299-56
   Devera R, 2003, MEM I OSWALDO CRUZ, V98, P1, DOI 10.1590/S0074-02762003000100001
   HARPHAM T, 1991, World Health Statistics Quarterly, V44, P62
   Hoffman W. A., 1934, Puerto Rico Journal of Public Health & Tropical Medicine, V9, P283
   Lessa I., 2001, MANUAL DOENCAS MAIS, P43
   Mascarini LM, 2006, REV SOC BRAS MED TRO, V39, P577, DOI 10.1590/S0037-86822006000600015
   NOKES C, 1992, PARASITOLOGY, V104, P539, DOI 10.1017/S0031182000063800
   OPARIL S., 2003, ANN INTERNAL MED PHI, V139, P61
   Pinto Erika de Paula Pedro, 2006, Acta Bot. Bras., V20, P751, DOI 10.1590/S0102-33062006000400001
   Rey L., 2001, PARASITOLOGIA
   Rocha R S, 2000, Rev Soc Bras Med Trop, V33, P431
   Santos L. P., 2007, Revista de Patologia Tropical, V36, P237
   Santos-Junior G. O., 2006, Revista de Patologia Tropical, V35, P233
   SATURNINO A. C. R. D., 2003, REV BRASILERIA ANALI, V35, P82
   Silva José Antonio Novaes da, 2007, Saude soc., V16, P111, DOI 10.1590/S0104-12902007000200011
   Tsuyuoka R, 1999, Cad Saude Publica, V15, P413, DOI 10.1590/S0102-311X1999000200026
NR 25
TC 5
Z9 9
U1 0
U2 2
PU UNIV FEDERAL UBERLANDIA
PI UBERLANDIA
PA AV PARA, 1720 CAMPUS UMUARAMA, UBERLANDIA, 38400-902, BRAZIL
SN 1981-3163
J9 BIOSCI J
JI Biosci. J.
PD JUL-AUG
PY 2013
VL 29
IS 4
BP 1049
EP 1057
PG 9
WC Agriculture, Multidisciplinary; Agronomy; Biology
SC Agriculture; Life Sciences & Biomedicine - Other Topics
GA 206VJ
UT WOS:000323551900030
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU da Silva, RAA
   Tavares, NM
   Costa, D
   Pitombo, M
   Barbosa, L
   Fukutani, K
   Miranda, JC
   de Oliveira, CI
   Valenzuela, JG
   Barral, A
   Soto, M
   Barral-Netto, M
   Brodskyn, C
AF da Silva, Robson A. A.
   Tavares, Natalia M.
   Costa, Dirceu
   Pitombo, Maiana
   Barbosa, Larissa
   Fukutani, Kyioshi
   Miranda, Jose C.
   de Oliveira, Camila I.
   Valenzuela, Jesus G.
   Barral, Aldina
   Soto, Manuel
   Barral-Netto, Manoel
   Brodskyn, Claudia
TI DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein
   protects hamsters against visceral leishmaniasis
SO ACTA TROPICA
LA English
DT Article
DE Hamster; Leishmonia chagasi; Visceral leishmaniasis; Saliva; DNA
   plasmids; Protection
ID KINETOPLASTID MEMBRANE PROTEIN-11; SAND FLY SALIVA; IMMUNE-RESPONSE;
   BALB/C MICE; CUTANEOUS LEISHMANIASIS; VECTOR SALIVA; MESSENGER-RNA;
   NITRIC-OXIDE; MODEL; MACROPHAGES
AB It was recently shown that immunization of hamsters with DNA plasmids coding LJM19, a sand fly salivary protein, partially protected against a challenge with Leishmania chagasi, whereas immunization with KMP11 DNA plasmid, a Leishmania antigen, induced protection against L donovani infection. In the present study, we evaluated the protective effect of immunization with both LJM19 and KMP11 DNA plasmid together. Concerning the protection against an infection by L chagasi, immunization with DNA plasmids coding LJM19 or KMP11, as well as with both plasmids combined, induced IFN-gamma production in draining lymph nodes at 7, 14 and 21 days post-immunization. Immunized hamsters challenged with L chagasi plus Salivary Gland Sonicate (SGS) from Lutzomyia longipalpis showed an enhancement of IFN-gamma/IL-10 and IFN-gamma/TGF-beta in draining lymph nodes after 7 and 14 days of infection. Two and five months after challenge, immunized animals showed reduced parasite load in the liver and spleen, as well as increased IFN-gamma/IL-10 and IFN-gamma/TGF-beta ratios in the spleen. Furthermore, immunized animals remained with a normal hematological profile even five months after the challenge, whereas L chagasi in unimmunized hamsters lead to a significant anemia. The protection observed with LJM19 or KMP11 DNA plasmids used alone was very similar to the protection obtained by the combination of both plasmids. (C) 2011 Elsevier B.V. All rights reserved.
C1 [da Silva, Robson A. A.; Tavares, Natalia M.; Costa, Dirceu; Pitombo, Maiana; Barbosa, Larissa; Fukutani, Kyioshi; Miranda, Jose C.; de Oliveira, Camila I.; Barral, Aldina; Barral-Netto, Manoel] Fiocruz MS, Ctr Pesquisas Goncalo Moniz CPqGM, BR-40296710 Salvador, BA, Brazil.
   [da Silva, Robson A. A.] Univ Fed Bahia UFBA, Inst Multidisciplinar Saude, Vitoria Da Conquista, BA, Brazil.
   [da Silva, Robson A. A.] Inst Ciencias Saude, Salvador, BA, Brazil.
   [da Silva, Robson A. A.] Fac Med, Salvador, BA, Brazil.
   [Brodskyn, Claudia] Inst Nacl Ciencia & Tecnol Invest Imunol Iii INCT, Sao Paulo, Brazil.
   [Soto, Manuel] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa SCIC UAM, E-28049 Madrid, Spain.
   [Valenzuela, Jesus G.] NIAID, Vector Mol Biol Sect, Lab Malaria & Vector Res, NIH, Bethesda, MD USA.
RP Brodskyn, C (corresponding author), Fiocruz MS, Lab Imunoregulacao LIMI, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM brodskyn@bahia.fiocruz.br
RI Barral-Netto, Manoel/B-3904-2009; Silva, Robson A A/N-8801-2018;
   Fukutani, Kiyoshi/N-7905-2016; Costa, Dirceu/D-7993-2013; Alvarez,
   Manuel Soto/Q-5234-2018; Fukutani, Kiyoshi/T-1630-2019; de Oliveira,
   Camila I/B-4358-2009; Tavares, Natalia/AAQ-1527-2020
OI Barral-Netto, Manoel/0000-0002-5823-7903; Fukutani,
   Kiyoshi/0000-0003-2223-0918; Costa, Dirceu/0000-0002-0334-3899; Alvarez,
   Manuel Soto/0000-0001-6825-841X; de Oliveira, Camila
   I/0000-0002-7868-5164; Machado Tavares, Natalia/0000-0002-4026-679X
FU FAPESB; CNPqNational Council for Scientific and Technological
   Development (CNPq); CAPESCAPES
FX We thank Edivaldo Passos for technical assistance. This research was
   supported by FAPESB, CNPq and CAPES. CB, AB, CIO and MB-N are senior
   investigators of CNPq-Brasil. RAAS received a fellowship from CNPq.
CR Andrade BB, 2007, SCAND J IMMUNOL, V66, P122, DOI 10.1111/j.1365-3083.2007.01964.x
   Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740
   Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160
   Basu R, 2007, J INFECT DIS, V195, P1373, DOI 10.1086/513439
   Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941
   Caldas AJM, 2006, ACTA TROP, V97, P252, DOI 10.1016/j.actatropica.2005.09.010
   Costa DJ, 2004, INFECT IMMUN, V72, P1298, DOI 10.1128/IAI.72.3.1298-1305.2004
   Dondji B, 2005, INFECT IMMUN, V73, P5286, DOI 10.1128/IAI.73.8.5286-5289.2005
   Fernandez-Guerrero ML, 2004, ACTA TROP, V90, P11, DOI 10.1016/j.actatropica.2003.09.009
   Fuertes MA, 2001, J BIOL INORG CHEM, V6, P107, DOI 10.1007/s007750000175
   Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613
   Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105
   Greenland JR, 2007, VACCINE, V25, P3731, DOI 10.1016/j.vaccine.2007.01.120
   Guilpin VO, 2002, PARASITE IMMUNOL, V24, P437, DOI 10.1046/j.1365-3024.2002.00484.x
   Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351
   Lima HC, 1997, PARASITOL TODAY, V13, P80, DOI 10.1016/S0169-4758(96)40010-2
   Lima HC, 1996, INFECT IMMUN, V64, P5442, DOI 10.1128/IAI.64.12.5442-5445.1996
   Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998
   Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912
   Moreno J, 2007, VACCINE, V25, P5290, DOI 10.1016/j.vaccine.2007.05.010
   Morris RV, 2001, J IMMUNOL, V167, P5226, DOI 10.4049/jimmunol.167.9.5226
   Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141
   Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085
   Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005
   Pastorino Antonio C., 2002, J. Pediatr. (Rio J.), V78, P120, DOI 10.1590/S0021-75572002000200010
   Ramirez JR, 2001, VACCINE, V20, P455, DOI 10.1016/S0264-410X(01)00341-3
   RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143
   Ribeiro JMC, 2001, J PARASITOL, V87, P915, DOI 10.1645/0022-3395(2001)087[0915:TSAACO]2.0.CO;2
   Sharma G, 2006, J DRUG TARGET, V14, P301, DOI 10.1080/10611860600809112
   Silva F, 2005, AM J TROP MED HYG, V72, P94, DOI 10.4269/ajtmh.2005.72.94
   THEODOS CM, 1991, INFECT IMMUN, V59, P1592, DOI 10.1128/IAI.59.5.1592-1598.1991
   TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436
   Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331
   Yarali N, 2002, AM J HEMATOL, V71, P191, DOI 10.1002/ajh.10200
NR 34
TC 23
Z9 24
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
J9 ACTA TROP
JI Acta Trop.
PD DEC
PY 2011
VL 120
IS 3
BP 185
EP 190
DI 10.1016/j.actatropica.2011.08.007
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 853LS
UT WOS:000297428400006
PM 21875567
OA Green Accepted, Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Tavares, NM
   Silva, RA
   Costa, DJ
   Pitombo, MA
   Fukutani, KF
   Miranda, JC
   Valenzuela, JG
   Barral, A
   de Oliveira, CI
   Barral-Netto, M
   Brodskyn, C
AF Tavares, Natalia M.
   Silva, Robson A.
   Costa, Dirceu J.
   Pitombo, Maiana A.
   Fukutani, Kiyoshi F.
   Miranda, Jose C.
   Valenzuela, Jesus G.
   Barral, Aldina
   de Oliveira, Camila I.
   Barral-Netto, Manoel
   Brodskyn, Claudia
TI Lutzomyia longipalpis Saliva or Salivary Protein LJM19 Protects against
   Leishmania braziliensis and the Saliva of Its Vector, Lutzomyia
   intermedia
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CUTANEOUS LEISHMANIASIS; IMMUNE-RESPONSE; MODEL; IDENTIFICATION;
   EXPRESSION; MICE
AB Background: Leishmania transmission occurs in the presence of insect saliva. Immunity to Phlebotomus papatasi or Lutzomyia longipalpis saliva or salivary components confers protection against an infection by Leishmania in the presence of the homologous saliva. However, immunization with Lutzomyia intermedia saliva did not protect mice against Leishmania braziliensis plus Lu. intermedia saliva. In the present study, we have studied whether the immunization with Lu. longipalpis saliva or a DNA plasmid coding for LJM19 salivary protein would be protective against L. braziliensis infection in the presence of Lu. intermedia saliva, the natural vector for L. braziliensis.
   Methodology/Principal Findings: Immunization with Lu. longipalpis saliva or with LJM19 DNA plasmid induced a Delayed-Type Hypersensitivity (DTH) response against Lu. longipalpis as well as against a Lu. intermedia saliva challenge. Immunized and unimmunized control hamsters were then intradermally infected in the ears with L. braziliensis in the presence of Lu. longipalpis or Lu. intermedia saliva. Animals immunized with Lu. longipalpis saliva exhibited smaller lesion sizes as well as reduced disease burdens both at lesion site and in the draining lymph nodes. These alterations were associated with a significant decrease in the expression levels of IL-10 and TGF-beta. Animals immunized with LJM19 DNA plasmid presented similar findings in protection and immune response and additionally increased IFN-gamma expression.
   Conclusions/Significance: Immunization with Lu. longipalpis saliva or with a DNA plasmid coding LJM19 salivary protein induced protection in hamsters challenged with L. braziliensis plus Lu. intermedia saliva. These findings point out an important role of immune response against saliva components, suggesting the possibility to develop a vaccine using a single component of Lu. longipalpis saliva to generate protection against different species of Leishmania, even those transmitted by a different vector.
C1 [Tavares, Natalia M.; Costa, Dirceu J.; Pitombo, Maiana A.; Fukutani, Kiyoshi F.; Miranda, Jose C.; Barral, Aldina; de Oliveira, Camila I.; Barral-Netto, Manoel; Brodskyn, Claudia] Fiocruz MS, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Silva, Robson A.] Univ Fed Bahia, Inst Multidisciplinar Saude, Vitoria Da Conquista, BA, Brazil.
   [Valenzuela, Jesus G.] NIAID, Vector Mol Biol Unit, Lab Malaria & Vector Res, NIH, Rockville, MD USA.
   [Barral, Aldina; de Oliveira, Camila I.; Barral-Netto, Manoel; Brodskyn, Claudia] Inst Invest Imunol, Sao Paulo, Brazil.
RP Tavares, NM (corresponding author), Fiocruz MS, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
EM brodskyn@bahia.fiocruz.br
RI Barral-Netto, Manoel/B-3904-2009; Silva, Robson A A/N-8801-2018; de
   Oliveira, Camila I/B-4358-2009; Tavares, Natalia/AAQ-1527-2020;
   Fukutani, Kiyoshi/N-7905-2016; Fukutani, Kiyoshi/T-1630-2019
OI Barral-Netto, Manoel/0000-0002-5823-7903; de Oliveira, Camila
   I/0000-0002-7868-5164; Fukutani, Kiyoshi/0000-0003-2223-0918; Machado
   Tavares, Natalia/0000-0002-4026-679X
FU FAPESB; Renorbio [554753/2006-5]; CNPqNational Council for Scientific
   and Technological Development (CNPq) [472973/2006-1]; NATIONAL INSTITUTE
   OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [ZIAAI000932,
   ZIAAI000932, ZIAAI000932, ZIAAI000932, ZIAAI000932, ZIAAI000932,
   ZIAAI000932, ZIAAI000932, ZIAAI000932, ZIAAI000932] Funding Source: NIH
   RePORTER
FX This work was supported by FAPESB, Renorbio (554753/2006-5) and CNPq
   (472973/2006-1). AB, CIO, MB-N and CB are senior investigators from
   CNPq. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Andrade BB, 2007, SCAND J IMMUNOL, V66, P122, DOI 10.1111/j.1365-3083.2007.01964.x
   Araujo-Santos T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000873
   Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941
   BITTENCOURT AL, 1991, MEM I OSWALDO CRUZ, V86, P51, DOI 10.1590/S0074-02761991000100009
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Collin N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000441
   Costa DJ, 2004, INFECT IMMUN, V72, P1298, DOI 10.1128/IAI.72.3.1298-1305.2004
   de Moura TR, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000084
   de Moura TR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000712
   de Oliveira CI, 2004, MICROBES INFECT, V6, P977, DOI 10.1016/j.micinf.2004.05.009
   Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105
   HERRER A, 1979, EXP PARASITOL, V48, P359, DOI 10.1016/0014-4894(79)90120-6
   Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351
   LABUDA M, 1993, MED VET ENTOMOL, V7, P193, DOI 10.1111/j.1365-2915.1993.tb00674.x
   Lima HC, 1996, INFECT IMMUN, V64, P5442, DOI 10.1128/IAI.64.12.5442-5445.1996
   Melby PC, 2001, EXP PARASITOL, V99, P17, DOI 10.1006/expr.2001.4640
   Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085
   Ribeiro JMC, 2001, J EXP BIOL, V204, P2001
   Teixeira MJ, 2005, INFECT IMMUN, V73, P1191, DOI 10.1128/IAI.73.2.1191-1195.2005
   Thiakaki M, 2005, MICROBES INFECT, V7, P760, DOI 10.1016/j.micinf.2005.01.013
   TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436
   TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x
   Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185
   Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331
   WILSON HR, 1979, EXP PARASITOL, V47, P270, DOI 10.1016/0014-4894(79)90079-1
NR 25
TC 44
Z9 45
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2011
VL 5
IS 5
AR e1169
DI 10.1371/journal.pntd.0001169
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 770OZ
UT WOS:000291099100037
PM 21655303
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Svensjo, E
   Batista, PR
   Brodskyn, CI
   Silva, R
   Lima, APCA
   Schmitz, V
   Saraiva, E
   Pesquero, JB
   Mori, MAS
   Muller-Esterl, W
   Scharfstein, J
AF Svensjo, E
   Batista, PR
   Brodskyn, CI
   Silva, R
   Lima, APCA
   Schmitz, V
   Saraiva, E
   Pesquero, JB
   Mori, MAS
   Muller-Esterl, W
   Scharfstein, J
TI Interplay between parasite cysteine proteases and the host kinin system
   modulates microvascular leakage and macrophage infection by
   promastigotes of the Leishmania donovani complex
SO MICROBES AND INFECTION
LA English
DT Article
DE Leishmaniasis; innate immunity; inflammation; macrophages; endothelium;
   kinins; angiotensin-converting enzyme; cysteine proteases
ID EXPERIMENTAL VISCERAL LEISHMANIASIS; ANGIOTENSIN-CONVERTING ENZYME;
   DELAYED-TYPE HYPERSENSITIVITY; TRYPANOSOMA-CRUZI; VASCULAR-PERMEABILITY;
   DENDRITIC CELLS; CHEEK POUCH; BRADYKININ; RECEPTORS; PROTEINASE
AB Kinins, the vasoactive peptides proteolytically liberated from kininogens, were recently recognized as signals alerting the innate immune system. Here we demonstrate that Leishmania donovani and Leishmania chagasi, two etiological agents of visceral leishmaniasis (VL), activate the kinin system. Intravital microscopy in the hamster cheek pouch showed that topically applied promastigotes induced macromolecular leakage (FITC-dextran) through postcapillary venules. Peaking at 15 min, the parasite-induced leakage was drastically enhanced by captopril (Cap), an inhibitor of angiotensin-converting enzyme (ACE), a kinin-degrading metallopeptidase. The enhanced microvascular responses were cancelled by HOE-140, an antagonist of the B, bradykinin receptor (13,R), or by pre-treatment of promastigotes with the irreversible cysteine proteinase inhibitor N-methylpiperazine-urea-Phe-homoPhe-vinylsulfone-benzene (N-Pip-hF-VSPh). In agreement with the above-mentioned data, the promastigotes vigorously induced edema in the paw of Cap-treated J129 mice, but not Cap-B2R-/(-) mice. Analysis of parasite-induced breakdown of high molecular weight kininogens (HK), combined with active site-affinity-labeling with biotin-N-Pip-hF-VSPh, identified 35-40 kDa proteins as kinin-releasing cysteine peptidases. We then checked if macrophage infectivity was influenced by interplay between these kinin-releasing parasite proteases, kininogens, and kinin-degrading peptidases (i.e. ACE). Our studies revealed that full-fledged B2R engagement resulted in vigorous increase of L. chagasi uptake by resident macrophages. Evidence that inflammatory macrophages treated with HOE-140 became highly susceptible to amastigote outgrowth, assessed 72 h after initial macrophage interaction, further suggests that the kinin/B2R activation pathway may critically modulate inflammation and innate immunity in visceral leishmaniasis. (c) 2005 Elsevier SAS. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil.
   Ctr Pesquisa Goncalo Moniz, LIP, BR-40295001 Salvador, BA, Brazil.
   Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BR-21949900 Rio De Janeiro, Brazil.
   Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil.
   Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-6000 Frankfurt, Germany.
RP Scharfstein, J (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, CCS Ilha Fundao, BR-21949900 Rio De Janeiro, Brazil.
EM scharf@biof.ufrj.br
RI Saraiva, Elvira M/L-2864-2017; Silva, Robson A A/N-8801-2018; Batista,
   Paulo Ricardo/E-8883-2013; Pesquero, Joao/C-1470-2012; Brodskyn,
   Claudia/A-9970-2010; Schmitz, Veronica P/D-2458-2013; Lima, Ana Paula
   CA/G-4122-2012; Svensjo, Erik/B-5026-2008
OI Saraiva, Elvira M/0000-0002-6388-5286; Batista, Paulo
   Ricardo/0000-0002-3399-174X; Pesquero, Joao/0000-0002-4507-632X;
   Schmitz, Veronica P/0000-0002-0865-133X; Svensjo,
   Erik/0000-0002-7356-1787; LIMA, ANA PAULA C. A./0000-0003-4631-2694
CR Ahmed S, 2003, INFECT IMMUN, V71, P401, DOI 10.1128/IAI.71.1.401-410.2003
   Aliberti J, 2003, J IMMUNOL, V170, P5349, DOI 10.4049/jimmunol.170.11.5349
   Belkaid Y, 2000, P NATL ACAD SCI USA, V97, P6704, DOI 10.1073/pnas.97.12.6704
   Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941
   BHOOLA KD, 1992, PHARMACOL REV, V44, P1
   BITTENCOURT AL, 1995, TROPICAL PATHOLOGY, V8, P597
   BJORK J, 1985, J IMMUNOL, V134, P1115
   BLACKWELL JM, 1985, J EXP MED, V162, P324, DOI 10.1084/jem.162.1.324
   Brown NJ, 1998, CIRCULATION, V97, P1411, DOI 10.1161/01.CIR.97.14.1411
   DelNery E, 1997, J BIOL CHEM, V272, P25713, DOI 10.1074/jbc.272.41.25713
   Dominguez M, 2002, J EXP MED, V195, P451, DOI 10.1084/jem.20011319
   Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725
   Engwerda CR, 2004, TRENDS PARASITOL, V20, P524, DOI 10.1016/j.pt.2004.08.009
   ERLANSSON M, 1991, PROSTAGLANDINS, V41, P157, DOI 10.1016/0090-6980(91)90028-E
   FARMER SG, 1992, ANNU REV PHARMACOL, V32, P511
   Ferreira J, 2002, NEUROPHARMACOLOGY, V43, P1188, DOI 10.1016/S0028-3908(02)00311-8
   FRIEDLAND J, 1978, BIOCHEM BIOPH RES CO, V83, P843, DOI 10.1016/0006-291X(78)91471-7
   Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613
   Gomes RB, 2002, J INFECT DIS, V186, P1530, DOI 10.1086/344733
   Gorak PMA, 1998, EUR J IMMUNOL, V28, P687, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;687::AID-IMMU687&gt;3.0.CO;2-N
   Goto H, 2004, BRAZ J MED BIOL RES, V37, P615, DOI 10.1590/S0100-879X2004000400020
   HASAN AAK, 1995, J BIOL CHEM, V270, P19256, DOI 10.1074/jbc.270.33.19256
   Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665
   IMAMURA T, 1994, J CLIN INVEST, V94, P361, DOI 10.1172/JCI117330
   KAUFMANN J, 1993, J BIOL CHEM, V268, P9079
   Kozik A, 1998, J BIOL CHEM, V273, P33224, DOI 10.1074/jbc.273.50.33224
   Kropf P, 2004, J LEUKOCYTE BIOL, V76, P48, DOI 10.1189/jlb.1003484
   Laurenti MD, 1996, INT J EXP PATHOL, V77, P15, DOI 10.1046/j.1365-2613.1996.958096.x
   Lima APCA, 2002, J BIOL CHEM, V277, P5875, DOI 10.1074/jbc.M108518200
   Lonardoni MVC, 2000, INFECT IMMUN, V68, P6355, DOI 10.1128/IAI.68.11.6355-6361.2000
   Maeda H, 1996, BIOL CHEM H-S, V377, P217
   Marceau F, 1998, CLIN REV ALLERG IMMU, V16, P385, DOI 10.1007/BF02737658
   Matte C, 2002, J INFECT DIS, V185, P673, DOI 10.1086/339260
   Mottram JC, 1998, CURR OPIN MICROBIOL, V1, P455, DOI 10.1016/S1369-5274(98)80065-9
   Mundodi V, 2002, GENE, V282, P257, DOI 10.1016/S0378-1119(01)00851-4
   RAMAMOORTHY R, 1992, J BIOL CHEM, V267, P1888
   Rao CM, 1999, J PARASITOL, V85, P682, DOI 10.2307/3285743
   Renne T, 2000, J BIOL CHEM, V275, P33688, DOI 10.1074/jbc.M000313200
   RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335
   Rosenthal LA, 1996, INFECT IMMUN, V64, P2206, DOI 10.1128/IAI.64.6.2206-2215.1996
   Rubinstein I, 2001, INFECT IMMUN, V69, P1199, DOI 10.1128/IAI.69.2.1199-1201.2001
   SCHAFSTEIN J, 2003, MOL MECH PATHOGENEIS
   Scharfstein J, 2000, J EXP MED, V192, P1289, DOI 10.1084/jem.192.9.1289
   Shariat-Madar Z, 1999, J BIOL CHEM, V274, P7137, DOI 10.1074/jbc.274.11.7137
   Shigematsu S, 2002, AM J PHYSIOL-HEART C, V283, pH2676, DOI 10.1152/ajpheart.00538.2002
   Shigematsu S, 1999, AM J PHYSIOL-HEART C, V277, pH152
   Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656
   SVENSJO E, 1984, MICROCIRC ENDOTH LYM, V1, P381
   Svensjo E, 1990, Eur Respir J Suppl, V12, p595s
   Svensjo E, 1997, MICROVASC RES, V54, P93, DOI 10.1006/mvre.1997.2020
   SVENSJO E, 1978, PROSTAG LEUKOTR ESS, V1, P397, DOI 10.1016/0161-4630(78)90126-X
   Todorov AG, 2002, FASEB J, V16, P73, DOI 10.1096/fj.02-0477fje
   WILSON ME, 1988, INFECT IMMUN, V56, P363, DOI 10.1128/IAI.56.2.363-369.1988
NR 53
TC 24
Z9 25
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD JAN
PY 2006
VL 8
IS 1
BP 206
EP 220
DI 10.1016/j.micinf.2005.06.016
PG 15
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 013WW
UT WOS:000235441700024
PM 16203170
OA Green Published
DA 2020-12-08
ER

EF